phosphorus has been researched along with Chronic Disease in 261 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 97 (37.16) | 18.7374 |
| 1990's | 29 (11.11) | 18.2507 |
| 2000's | 77 (29.50) | 29.6817 |
| 2010's | 55 (21.07) | 24.3611 |
| 2020's | 3 (1.15) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadkhaniha, HR; Alavi, K; Arya, S; Ebrahimi, A; Kamyab, A; Kamyab, P; Pourmehdiardebili, M; Sanatkar, SA; Zarei, Z | 1 |
| Kim, E; Kim, S; Ryu, E | 1 |
| Castellino, P; Fatuzzo, P; Gaudio, A; Granata, A; Lentini, P; Malatino, L; Rapisarda, F; Sessa, C; Xourafa, A; Zanoli, L | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Craig, JC; Elder, GJ; Natale, P; Palmer, SC; Ruospo, M; Strippoli, GF; Vecchio, M | 1 |
| Brunini, F; Capone, V; Cozzolino, M; Cusi, D; Kwaidri, Y; Montanari, E; Ricca, F | 1 |
| Azizov, AN; Babichev, AV; Gil'miiarov, EM; Golovina, ES; Kolesova, KI; Radomskaia, VM; Sazonova, EA; Tlustenko, VP | 1 |
| Calvo, MS; Uribarri, J | 1 |
| Berenguer, L; Capra, R; Castellano, M; Chiurchiu, CR; de Arteaga, J; de La Fuente, JL; Douthat, WG; Garay, G; Guzmán, MA; Massari, PU | 1 |
| Abad, S; Ampuero, J; Aragoncillo-Sauco, I; Barraca, D; López-Gómez, JM; Ruiz-Caro, C; Vega-Martínez, A; Verdalles-Guzmán, Ú; Yuste, C | 1 |
| Álvarez, V; Bernis, C; Bomback, AS; Coronel, F; de Lorenzo, A; Moya, M; Salanova, L; Sánchez-Tomero, JA | 1 |
| Craig, JC; Hahn, D; Hodson, EM | 1 |
| Anger, M; Fishbane, S; Martin, KJ; Mehrotra, R; Sprague, SM; Zeig, S | 1 |
| Yokoyama, K | 2 |
| Belozeroff, V; Danese, MD; Rothman, KJ; Smirnakis, K | 1 |
| Chonchol, MB; Kendrick, J | 1 |
| Valdivieso, JM | 1 |
| Fernandez Giraldez, E; Sánchez González, MC; Valdivielso Revilla, JM | 1 |
| Bammens, B; Claes, K; de Jonge, H; Evenepoel, P; Kuypers, D; Meijers, BK; Naesens, M; Vanrenterghem, Y | 1 |
| Charytan, C; Corry, DB; Fishbane, S; Goodman, WG; Ling, X; Rappaport, K; Roppolo, M; Shapiro, WB; Turner, S; Vicks, SL | 1 |
| Bernal, M; Chalian, A; Covic, A; Goldsmith, D; Kothawala, P; Robbins, S | 1 |
| Alper, A; Hyre, AD; Jones, TM; Leonard, MB; Melamed, ML; Muntner, P; Raggi, P | 1 |
| Abboud, H; Dauphin, M; Finn, W; Qiu, P; Sprague, SM; Zhang, P | 1 |
| Cannata-Andía, JB; Naves-Díaz, M | 1 |
| Fukagawa, M; Komaba, H | 1 |
| Tanaka, M | 1 |
| Craig, JC; Palmer, SC; Strippoli, GF | 1 |
| Adeney, KL; De Boer, IH; Duprez, DA; Ix, JH; Jenny, NS; Kestenbaum, BR; Peralta, CA; Siscovick, DS | 1 |
| Fouque, D; Goldstein-Fuchs, J | 1 |
| Aframian, DJ; Davidovich, E; Davidovits, M; Peretz, B; Shapira, J | 1 |
| Inaguma, D; Tatematsu, M | 1 |
| Inaba, M | 1 |
| Brown, CG | 1 |
| Bugeja, A; Dacouris, N; Donnelly, S; Goldstein, M; Marticorena, R; McFarlane, P; Thomas, A | 1 |
| Collins, AJ; Snyder, JJ | 1 |
| Fukagawa, M; Goto, S | 1 |
| Laggouranis, A; Manios, E; Psimenou, E; Tsagalis, G | 1 |
| Blough, DK; Johnson, ES; Petrik, A; Smith, DH; Thorp, ML; Yang, X | 1 |
| Curzi, MP; Evenepoel, P; González, MT; Husserl, FE; Kopyt, N; Mix, C; Sprague, SM; Sterling, LR; Wong, G | 1 |
| Wolf, M | 2 |
| García, J; Herrera, H; Mora-Fernández, C; Muros, M; Navarro-González, JF | 1 |
| Finkelstein, FO; Kliger, AS | 1 |
| Shaheen, FA; Souqiyyeh, MZ | 1 |
| Peacock, M | 1 |
| Craig, JC; Geary, DF; Hodson, EM | 1 |
| Coyne, D; Sprague, SM | 1 |
| Bellinghieri, G; Santoro, D; Savica, V | 1 |
| Aires, I; Amaral, T; Borges, M; Cortez, J; Ferreira, A; Ferreira, C; Gil, C; Jorge, C; Matias, PJ | 1 |
| Bouchet, JL; Drueke, T; Fouque, D; London, G; Pelletier, S; Roth, H | 1 |
| Bostom, AG; Hanlon, WA; Kuznetsova, O; Maccubbin, D; Tipping, D | 1 |
| Crncevic, Z; Orlic, L; Pavlovic, D; Zaputovic, L | 1 |
| Braga, S; Cannata-Andía, JB; Carrillo-López, N; Fernández-Coto, T; López-Hernández, F; Lopez-Novoa, JM; Naves-Díaz, M; Rodríguez-Rodríguez, A | 1 |
| Cutler, GB; Dowdy, K; Peterson, D; Reynolds, J; Sinaii, N; Winer, KK | 1 |
| Martin, KJ; Qazi, RA | 1 |
| Akcay, A; Armutcu, F; Aydin, M; Covic, A; Duranay, M; Eryonucu, B; Ikizek, M; Kanbay, M; Nicoleta, M; Selcoki, Y | 1 |
| Fujii, N | 1 |
| Komaba, H | 1 |
| Joki, N; Tanaka, Y | 1 |
| Taniguchi, M | 1 |
| Koiwa, F; Maruta, Y | 1 |
| Dobronravov, VA; Rafrafi, H; Smirnov, AV; Volkov, MM | 1 |
| Bobkova, IN; Dobrosmyslov, IA; Kozlovskaia, LV; Milovanov, IuS; Milovanova, LIu | 1 |
| Dobre, M; Kandula, P; Mehrotra, R; Navaneethan, SD; Schold, JD; Schreiber, MJ | 1 |
| Drüeke, TB | 1 |
| Coyne, D; Hruska, K; London, G; Malluche, HH; Martin, KJ | 1 |
| Adragao, T; Apostolous, T; Bellasi, A; Cozzolino, M; Gallieni, M; Missaglia, E; Ortiz, A; Vescovo, G | 1 |
| Amezquita Orjuela, Y; Caldés Ruisánchez, S; Fernández Lucas, M; Fernández Rodríguez, A; Galeano Álvarez, C; Marcén Letosa, R; Quereda Rodríguez-Navarro, C; Rivera Gorrin, M; Teruel Briones, JL | 1 |
| Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF; Vecchio, M | 1 |
| Fang, Y; Hruska, K; Lund, R; Mathew, S; Sugatani, T | 1 |
| Christensson, A; Fernström, A; Giæver, J; Granroth, B; Hylander, B; Jacobson, SH; Jensen, G; Weiss, L; Wikström, B; Wrege, U | 1 |
| Baldrati, L; Bellasi, A; Corradini, M; Di Nicolò, P; Malmusi, G; Mandreoli, M; Santoro, A | 1 |
| Fukagawa, M; Itoh, K; Kadowaki, D; Komaba, H; Maruyama, T; Matsushita, K; Otagiri, M; Tanaka, M; Tokunaga, K; Watanabe, H | 1 |
| Arenas, L; Bover, J; Cannata Andía, J; Caravaca, F; de Francisco, AL; Fernández Giráldez, E; González Parra, E; Lorenzo, V; Martín-Malo, A; Martínez, I; Rodríguez Portillo, M; Torregrosa, JV; Torres, A | 1 |
| Block, GA | 1 |
| Morishita, R; Nakagami, H | 1 |
| Cannata-Andía, JB; Mejía, N; Miar, AB; Roman-García, P; Tavira, B | 1 |
| Cornago, I; Gallardo, I; García-Ledesma, P; Hernando, A; Martinez, I; Montenegro, J; Muñoz, RI; Romero, MA | 1 |
| Caravaca, F; Cerezo, I; Ferreira, F; García de Vinuesa, E; Hernández-Gallego, R; Macías, R; Martínez del Viejo, C; Martínez Gallardo, R; Villa, J | 1 |
| Cerezo Morales, S; Hervás Sánchez, JG; Polo Moyano, A; Prados Garrido, MD | 1 |
| Miyamoto, K; Nomura, K; Ohi, A | 1 |
| Rodriguez, M; Silver, J; Slatopolsky, E | 1 |
| Lieberman, RL; Phelps, KR | 1 |
| Flanigan, M; Haynes, WG; Kalil, RS; Stanford, W | 1 |
| Iwasaki, M; Joki, N | 1 |
| Imanishi, Y | 1 |
| Bacic, B; Bosnjak, T; Kovacic, V; Roguljic, L | 1 |
| Buist, R; Corbin, IR; Minuk, GY; Peeling, J; Uhanova, J; Zhang, M | 1 |
| EASSON, EC; JONES, BE; MACKENZIE, LA | 1 |
| SHAY, H; SUN, DC; ZARAFONETIS, CJ | 1 |
| NEELY, CL; REINHARD, EH; SAMPLES, DM | 1 |
| KISELEVA, AN; KUZ'MIN, DS; POVERGO, NS; ROZANOVA, LM; SHERMAN, SI; VAKULENKO, AD | 2 |
| ANTIC, M; RADOJICIC, B | 1 |
| CATANIA, A; PAGLIARO, L; RINALDI, A | 1 |
| OSGOOD, EE; SEAMAN, AJ; TIVEY, H | 1 |
| BRUGEL, H | 1 |
| BHATTACHARJEE, SB; DAS GUPTA, NN; LALA, PK | 1 |
| DAVISON, KB; LI, JG; OSGOOD, EE; SEAMAN, AJ; TIVEY, H | 1 |
| Bishop, CW; Coburn, JW; Elangovan, L; Germain, MJ; Lindberg, JS; Maung, HM; Sprague, SM; Williams, ME | 1 |
| Brook, RA; Pai, AB; Smeeding, JE | 1 |
| Collins, MT; Econs, MJ; Gupta, A; Marx, SJ; Winer, K | 1 |
| Ito, H; Kinugasa, E | 1 |
| Akiba, T; Tanabe, K; Tokumoto, T; Toma, H | 1 |
| Akizawa, T; Sakaguchi, T | 1 |
| Cattley, RC; Colloton, M; Henley, C; Lacey, D; Martin, D; Shatzen, E; Towler, DA | 1 |
| Graves, KL; Hellman, RN; Karp, SL; Kraus, M; LaClair, RE; Li, Q; Moe, SM; Ofner, S | 1 |
| Holick, MF | 1 |
| Iwamoto, J; Sato, Y; Takeda, T; Uzawa, M | 1 |
| Charytan, C; Chonchol, M; Coburn, JW; Herman, J; Klassen, PS; Lien, YH; Liu, W; McCary, LC; Pichette, V | 1 |
| Cimrin, D; Gol, M; Irmak, E; Uretmen, S | 1 |
| Beck, GJ; Collins, AJ; Greene, T; Kusek, JW; Levey, AS; Menon, V; Pereira, AA; Sarnak, MJ; Wang, X | 1 |
| Li, CF; Yang, ZJ | 1 |
| Qunibi, WY | 1 |
| Brooks, T; Candiani, C; Hudson, JQ; Joy, MS; Kshirsagar, A | 1 |
| Abboud, H; Anger, M; Batlle, D; Coyne, D; Hippensteel, R; Kavanaugh, A; Lunde, N; Melnick, JZ; Palaparthy, RV; Pradhan, RS; Qiu, P; Smolenski, O; Williams, LA | 1 |
| Brandenburg, VM; Chertow, GM; Ix, JH; Ketteler, M; Shlipak, MG; Whooley, MA | 1 |
| Drüeke, TB; Landais, P | 1 |
| Young, EW | 1 |
| Fadem, SZ; Moe, SM | 1 |
| Brown, AJ; Clagett-Dame, M; DeLuca, HF; Finch, JL; Mizobuchi, M; Plum, LA; Ritter, CS; Sicinski, RR; Slatopolsky, E | 1 |
| Collins, AJ; Foley, RN; Ishani, A; Wang, C | 1 |
| Honkanen, TT; Kööbi, P; Mustonen, JT; Niemelä, OJ; Pörsti, IH; Rantala, IS; Repo, JM; Ruskoaho, HJ; Rysä, JM; Tahvanainen, AM; Tikkanen, I | 1 |
| Bushinsky, DA | 1 |
| Chertow, GM; Moe, SM | 1 |
| Kalantar-Zadeh, K; Kovesdy, CP; Schwarz, S; Trivedi, BK | 1 |
| Kalantar-Zadeh, K; Kovesdy, CP | 2 |
| Blair, AT; Burke, SK; Cangiano, JL; Chasan-Taber, S; Dillon, MA; Fischer, D; Garrett, L; Ling, BN; Reed, J; Suki, WN; Zabaneh, R | 1 |
| Choe, JY; Kim, JY; Kim, SK; Park, SH; Shin, IH | 1 |
| Silver, J | 1 |
| Yano, S | 1 |
| Blair, A; Bleyer, AJ; Block, G; Chasan-Taber, S; Delmez, J; Dillon, M; Robertson, J | 1 |
| Goswami, R; Gupta, N; Ray, D; Singh, N; Tomar, N | 1 |
| Calvo, MS; Chen, SC; Collins, AJ; Li, S; McCullough, PA; Norris, KC; Uribarri, J; Vassalotti, JA; Wang, C; Whaley-Connell, AT | 1 |
| Chaudhary, LR; Hruska, KA; Mathew, S; Rifas, L; Sugatani, T; Tustison, KS | 1 |
| Chertow, GM; Hsu, CY; Hsu, J; Johansen, KL; Kaysen, GA | 1 |
| Chasan-Taber, S; Duggal, A; Fan, S; Heaton, J; Kalra, PA; Ketteler, M; Oestergaard, O; Pritchard, N; Rix, M | 1 |
| Messa, P | 1 |
| Danziger, J | 1 |
| Mao, L | 1 |
| Beloskurskaia, GI; Korol'chuk, EI | 1 |
| Alvestrand, A; Bergström, J; Fürst, P; Hultman, E; Widstam-Attorps, U | 1 |
| Nelson, DM; Richards, SR; Zuspan, FP | 1 |
| Aĭtbembetov, BN; Beloskurskaia, GI; Berdykhodzhin, MT; Dzhanabaev, DD; Paraskevopulos, IaG | 1 |
| Derevianko, NA; Iagoda, AV; Mosin, VM; Salanda, BS | 1 |
| Streliukhina, NA | 1 |
| Balmakhaeva, RM; Beloskurskaia, GI | 1 |
| Calabrese, G; Deicken, RF; Fein, G; Merrin, EL; Vinogradov, S; Weiner, MW | 1 |
| Aparicio, A; Caravaca, F; Cid, MC; Cubero, JJ; Jimenez, F; Liso, J; López, JM; Pizarro, JL; Santos, I | 1 |
| Aparicio, M; Blanchetier, V; Combe, C; de Précigout, V; Larroumet, N; Pommereau, A; Potaux, L | 1 |
| Bailey, JL; England, BK; Long, RC; Mitch, WE; Weissman, J | 1 |
| Barbiroli, B; Iotti, S; Klopstock, T; Lodi, R; Medori, R; Reichmann, H; Seibel, P; Tritschler, HJ; Zaniol, P | 1 |
| Ardissino, GL; Assael, BM; Bettinelli, A; Castiglioni, G; Claris-Appiani, A; Cunazza, M; Daccò, V; Pecchio, F; Tirelli, AS; Tischer, MC | 1 |
| Cox, IJ; Harris, M; Menon, DK; Morgan, MY; Sargentoni, J; Taylor-Robinson, SD | 1 |
| Bell, JD; Bryant, DJ; Coutts, GA; Mallalieu, RJ; Morgan, MY; Sargentoni, J; Taylor-Robinson, SD | 1 |
| Dauletbakova, MI; Gorblianskiĭ, IuIu | 1 |
| Adler, S; Verbalis, JG; Williams, D | 1 |
| Caner, H; Handa, Y; Kaneko, M; Kobayashi, H; Kubota, T; Tsuchida, A | 1 |
| Cutler, GB; Winer, KK; Yanovski, JA | 1 |
| Brandi, L; Daugaard, H; Egsmose, C; Jensen, LT; Nielsen, PK; Olgaard, K | 1 |
| Atkinson, SA; Paes, B; Shah, JK; Weiler, HA | 1 |
| Bassali, J; Gopalsami, C; Kazuko, E; Lawrence, AM; Paloyan Walker, R; Paloyan, E | 1 |
| Esato, K; Fujimura, Y; Hamano, K; Ito, H; Suzuki, K | 1 |
| Belan, V; Dobrota, D; Horecký, J; Kasparová, S; Liptaj, T; Mlynárik, V | 1 |
| Canaran, G; Carr, T; Drost, DJ; Neufeld, RW; Potwarka, JJ; Rylett, WJ; Williamson, PC | 1 |
| Miglioli, M; Paganelli, F; Pironi, L; Pizzoferrato, A; Ruggeri, E; Zolezzi, C | 1 |
| Brand, R; Conneman, N; Holscher, HC; Kist-van Holthe, JE; Schell-Feith, EA; van der Heijden, BJ; van Zwieten, PH; Zonderland, HM | 1 |
| Alamoudi, OS | 1 |
| Chen, EL; Fieno, DS; Judd, RM; Kim, RJ; Rehwald, WG | 1 |
| Munushkin, ON | 1 |
| Bouda, J; Dvorrák, R; Illek, J; Jagos, P; Jurajdová, J | 1 |
| Khalikov, TR; Saidkarimov, SK | 1 |
| Balsan, S; Deluca, HF; Garabedian, M; Holick, MF; Sorgniard, R | 1 |
| Adams, JS; Lukert, BP | 1 |
| Ajzen, H; Beppu, OS; dos Santos, ML; Ramos, OL; Stabile Neto, C | 1 |
| Knochel, JP | 1 |
| Goridova, LD; Leont'eva, FS; Timoshenko, OP | 1 |
| Akanuma, Y; Goodman, DS; Imawari, M; Itakura, H; Kosaka, K; Muto, Y | 1 |
| Conger, JD; Hammond, WS; Huffer, WE; Kuzela, DC; Winter, SD | 1 |
| Isakhanova, II; Makarov, VK; Zhdanova, TG | 1 |
| Baron, D; Hagedorn, M; Petres, J | 1 |
| Chudnovskaia, MV; Rodoman, VE; Viting, TA | 1 |
| Mori, R; Nishii, T; Wakabayashi, A | 1 |
| Bilbrey, GL; Carter, NW; Fuller, TJ; Knochel, JP | 1 |
| D'Angelo, A; Fiaschi, E; Maschio, G; Mioni, G; Ossi, E | 1 |
| Dube, B; Katiyar, BC; Skaria, J; Srivastava, TP | 1 |
| Vediaev, IP | 1 |
| Butler, KS; de la Torre, JC; de Socarraz, H; Fortin, T; Kozlowski, P; Pappas, BA; Park, GA; Richard, MT; Saunders, JK | 1 |
| Lukashev, AA; Mamyrbaev, AA; Streliukhina, NA | 1 |
| Striker, GE | 1 |
| Titov, VN; Tvorogova, MG | 1 |
| Hubesch, B; Matson, GB; Sappey-Marinier, D; Weiner, MW | 1 |
| Dzharbusynov, BU; Merkusheva, NV; Shalekenov, BU | 1 |
| Berger, OG; Bornschein, RL; Koo, WW; Krug-Wispe, SK; Steinchen, JJ; Succop, PA; Tsang, RC | 1 |
| Isogai, Y | 1 |
| Vileisis, RA | 1 |
| Iriguchi, N; Matsumoto, S; Tamaki, N; Yamamoto, T; Yasuda, M | 1 |
| Ormanov, NZh | 2 |
| Basile, C; Bourdeau, A; Bourdon, R; Drüeke, T; Dubost, C; Grateau, G; Lacour, B; Ureña, P; Vassault, A; Zingraff, J | 1 |
| Kutafina, EK; Naumova, VI; Panchenko, EL; Rusnak, FI; Vereskova, SA | 1 |
| Bauer, P; Bollaert, PE; Escanye, JM; Lambert, H; Larcan, A; Robert, J; Robin-Lherbier, B | 1 |
| Heubi, JE; Hollis, BW; Specker, B; Tsang, RC | 1 |
| Amico, A; Betti, L; Cotrozzi, G; Lupi, R; Relli, P | 1 |
| Beloskurskaia, GI; Ergeshbaev, KE | 1 |
| Bushinsky, DA; Coe, FL; Favus, MJ; Riera, GS | 1 |
| Adelman, RD; Ahlfors, CE; Ezzedeen, F | 1 |
| Bouillon, R; Bourdeau, JE; Brommage, R; Langman, CB; Miller, SC; Smith, R | 1 |
| Dmitriev, AI; Orynbaev, TO | 1 |
| Iakubov, ES; Knarat'ian, NA; Kokueva, OV; Radbil', OS | 1 |
| Masada, H | 1 |
| Balabolkin, MI; Khasanova, ER; Mkrtumian, AM | 1 |
| Konomi, G; Kozuki, Y; Minoda, H; Nakao, M; Shirai, T | 1 |
| Kozłowski, K; Lorenc, RS; Ruszczak, A; Ryzko, J; Socha, J | 1 |
| Karabalin, S; Rys-Uly, M | 1 |
| Basile, C; Di Maggio, A; Gugliotta, F; Manente, G; Scatizzi, A | 1 |
| Berezin, IP; Dmitriev, AI; Epshteĭn, IM; Orynbaev, TO | 1 |
| Lau, K; Rodriguez Nichols, F; Tannen, RL | 1 |
| Aĭdarkhanov, BB; Kuanyshbekova, RT; Shalkharov, SSh; Sharmanov, TSh | 1 |
| Aĭtbembetov, BN | 1 |
| Baldi, R; Barsotti, G; Caprioli, R; Carbone, C; Ciardella, F; Cupisti, A; Morelli, E; Niosi, F; Petronio, G | 1 |
| Cornish, CJ; Frankel, TL; McDowall, DB; Seshadri, MS | 1 |
| Doroguntseva, IN; Ermolenko, VM; Mozzhechkov, VT; Nikiforova, NV; Strunin, SE | 1 |
| Duck, HJ; Herrmann, W; Wagner, J | 1 |
| Miller, RG | 1 |
| Ibragimova, AA | 1 |
| Lipko, MR; Tsariuk, NB | 1 |
| Okudaira, M | 1 |
| Issautier, R; Mion, C; Mirouze, J; Thévenet, A | 1 |
| Ammann, R; Bihrer, R; Binswanger, U; Clavadetscher, P; Fumagalli, I; Funk, C; Leemann, A; Mayor, G; Seiler, P; Stuby, K | 1 |
| Schalm, OW | 1 |
| Degtiar, VV | 1 |
| Smirnov, VK | 1 |
| Gröndahl, HG; Hugoson, A; Lindhe, J; Svanberg, G | 1 |
| Bohmer, T | 1 |
| Corvaglia, E | 1 |
| Kravets, MG | 1 |
| Podgorodnikova, NA; Zlatkina, TI | 1 |
| Bedakovskiĭ, VF; Pliushchev, VD; Sviripa, EV | 1 |
| Bochman, NL; Ermolenko, VM; Migunova, NA; Nikiforova, NV; Rassokhin, BM | 1 |
| Block, AJ; Hinkes, C; Keitt, AS | 1 |
| Chisolm, JJ | 1 |
| Hasumura, Y; Hayakawa, H; Hirose, S; Nishimura, K; Sawabu, N | 1 |
| Cotton, KE; Gutch, CF; Holmes, JH; Huntley, R; Mahoney, J; Nelson, ME; Pinggera, WF | 1 |
| Hagstam, KE | 1 |
| François, B; François, R; Frederich, A; Pernod, J; Pouillaude, JM; Racle, P | 1 |
| Groen, JJ; Menczel, J; Shapiro, S | 1 |
| Flink, EB; Jacobs, WH; Jones, JE; Shane, SR | 1 |
| Friis, T; Weeke, E | 1 |
| Goto, K | 1 |
| Krebs, A; Kuske, H | 1 |
| Ballinger, WF; Haff, RC | 1 |
| Bazzato, G; Campanacci, L; Maschio, G; Mioni, G; Poli, D; Riz, G; Rizzo, A | 1 |
| Burton, BT; Gombos, EA; Hendler, ED; Hendler, RG; Magill, JW | 1 |
| Kracht, J; Kuhlencordt, F | 1 |
| Bell, NH; Bundesen, W; Del Greco, F; Kim, D; Putong, P; Simon, NM; Walker, C | 1 |
| Gardner, RJ; Koppel, DM | 1 |
| Dunn, MJ; Regal, EM; Schrier, RW; Tannen, RL | 1 |
| Kaplan, G | 1 |
55 review(s) available for phosphorus and Chronic Disease
| Article | Year |
|---|---|
[Vascular dysfunction in Cardiorenal Syndrome type 4].
Topics: Aorta; Arginine; Autonomic Nervous System Diseases; Bone Diseases, Metabolic; Cardio-Renal Syndrome; Cardiovascular Diseases; Chronic Disease; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Inflammation; Myocardial Infarction; Oxidative Stress; Phosphorus; Renal Insufficiency, Chronic; Toxins, Biological; Tunica Intima; Uric Acid; Vascular Stiffness; Vasculitis | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Topics: Adult; Aged; Calcium; Calcium Compounds; Cause of Death; Chelating Agents; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Progression; Fibroblast Growth Factor-23; Humans; Hypercalcemia; Iron Compounds; Lanthanum; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer | 2018 |
[Role of vitamin D in the pathogenesis of chronic kidney disease].
Topics: Calcium; Cardiovascular Diseases; Chronic Disease; Diabetes Complications; Disease Progression; Early Diagnosis; Fibrosis; Homeostasis; Humans; Hyperparathyroidism, Secondary; Hypertension; Immune Tolerance; Inflammation; Kidney Diseases; Parathyroid Hormone; Phosphorus; Proteinuria; Receptors, Calcitriol; Vitamin D; Vitamin D Deficiency | 2013 |
Interventions for metabolic bone disease in children with chronic kidney disease.
Topics: Aluminum Hydroxide; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcitriol; Calcium; Calcium Carbonate; Child; Chronic Disease; Ergocalciferols; Humans; Kidney Diseases; Parathyroid Hormone; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Sevelamer; Vitamin D | 2015 |
Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
Topics: Albuminuria; Anemia; Calcium; Cardiovascular Diseases; Chronic Disease; Inflammation; Kidney Diseases; Oxidative Stress; Phosphorus; Risk Factors | 2008 |
[Experimental advances in mineral metabolism].
Topics: Animals; Calcinosis; Calcium; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Chronic Disease; Drug Evaluation, Preclinical; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Intestinal Absorption; Kidney; Kidney Diseases; Lanthanum; Phosphorus; Sodium-Phosphate Cotransporter Proteins | 2008 |
[Control of phosphorus and treatment with vitamin D in chronic kidney disease prior to the start of dialysis].
Topics: Calcifediol; Calcinosis; Calcitriol; Cardiovascular Diseases; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney Diseases; Lanthanum; Phosphorus; Polyamines; Prevalence; Renal Dialysis; Sevelamer; Vitamin D; Vitamin D Deficiency | 2008 |
Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease.
Topics: Calcium; Cardiovascular Diseases; Chronic Disease; Humans; Kidney Diseases; Minerals; Phosphorus; Risk Factors | 2009 |
[Disturbance of phosphorus metabolism in chronic kidney disease].
Topics: Biomarkers; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Hypophosphatemia; Kidney Diseases; Kidney Transplantation; Parathyroid Hormone; Phosphorus | 2009 |
[Management of phosphate in chronic kidney disease--Phosphorus control by hemodialysis with long treatment time].
Topics: Chronic Disease; Humans; Hyperphosphatemia; Kidney Diseases; Phosphorus; Prognosis; Renal Dialysis; Time Factors | 2009 |
[Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
Topics: Bone Diseases, Metabolic; Calcium Carbonate; Chronic Disease; Dialysis; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Diseases; Phosphorus; Vitamin D; Vitamin D Deficiency | 2009 |
[Chronic kidney disease (CKD) and bone. Impact of diabetes mellitus on the development of CKD-MBD].
Topics: Atherosclerosis; Blood Glucose; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Chronic Disease; Collagen; Diabetes Complications; Diabetes Mellitus; Glycation End Products, Advanced; Humans; Insulin Resistance; Kidney Diseases; Minerals; Parathyroid Hormone; Phosphorus | 2009 |
[Clinical aspect of recent progress in phosphate metabolism. Pathophysiology of secondary hyperparathyroidism in chronic kidney disease].
Topics: Animals; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Diseases; Parathyroid Hormone; Phosphorus; Vitamin D | 2009 |
Fibroblast growth factor 23 (FGF23) and the kidney.
Topics: Animals; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Homeostasis; Humans; Hypophosphatemia; Intestinal Absorption; Kidney; Kidney Diseases; Nephrolithiasis; Parathyroid Glands; Phosphates; Phosphorus | 2009 |
Fibroblast growth factor 23 and the future of phosphorus management.
Topics: Animals; Biomarkers; Calcitriol; Chelating Agents; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney Diseases; Patient Selection; Phosphorus; Predictive Value of Tests; Renal Dialysis; Reproducibility of Results; Risk Assessment; Up-Regulation | 2009 |
Calcium metabolism in health and disease.
Topics: Animals; Bone and Bones; Bone Remodeling; Calcium; Calcium, Dietary; Chronic Disease; Dietary Supplements; Homeostasis; Humans; Hypercalcemia; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Intestinal Mucosa; Kidney; Kidney Diseases; Metabolic Diseases; Nutrition Policy; Phosphates; Phosphorus; Vitamin D | 2010 |
Interventions for bone disease in children with chronic kidney disease.
Topics: Aluminum Hydroxide; Bone Density Conservation Agents; Bone Diseases; Calcitriol; Calcium; Calcium Carbonate; Child; Chronic Disease; Humans; Kidney Diseases; Parathyroid Hormone; Phosphorus; Polyamines; Sevelamer; Vitamin D | 2010 |
Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
Topics: Biomarkers; Calcium; Chronic Disease; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Renal Dialysis; Severity of Illness Index; Treatment Outcome; Vitamin D; Vitamin D Deficiency | 2010 |
Forging forward with 10 burning questions on FGF23 in kidney disease.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Acute Kidney Injury; Animals; Calcitriol; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Diseases; Parathyroid Hormone; Phosphorus; Risk Factors | 2010 |
Vitamin D in kidney disease: pathophysiology and the utility of treatment.
Topics: Animals; Calcium; Cardiovascular System; Chronic Disease; Dietary Supplements; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Diseases; Mice; Phosphorus; Vitamin D; Vitamin D Deficiency | 2010 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). CKD-MBD in CKD patients not yet on dialysis; Status Quo].
Topics: Bone Diseases, Metabolic; Calcium; Chronic Disease; Dialysis; Evidence-Based Medicine; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Humans; Kidney Diseases; Klotho Proteins; Phosphorus; Practice Guidelines as Topic; Vitamin D | 2010 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
Topics: Bone Density; Bone Diseases, Metabolic; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Klotho Proteins; Parathyroid Hormone; Phosphorus; Receptor, Fibroblast Growth Factor, Type 1; Vitamin D | 2010 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Atheroma and vascular calcification in hemodialysis patients].
Topics: Atherosclerosis; Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Phosphorus; Renal Dialysis; Risk Factors; Vascular Diseases | 2010 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality].
Topics: Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Cinacalcet; Humans; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Polyamines; Prognosis; Risk; Sevelamer; Survival Rate; Vascular Diseases; Vitamin D | 2010 |
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD].
Topics: Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Cinacalcet; Clinical Trials as Topic; Drug Therapy, Combination; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Vascular Diseases; Vitamin D | 2010 |
[Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and Klotho].
Topics: Calcium; Cardiovascular Diseases; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Homeostasis; Humans; Kidney Diseases; Klotho Proteins; Phosphorus | 2010 |
Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials.
Topics: Calcium; Chronic Disease; Dietary Supplements; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Kidney Diseases; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic; Vitamin D | 2011 |
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients.
Topics: Bone Diseases, Metabolic; Calcium; Calcium Compounds; Chelating Agents; Chronic Disease; Humans; Hypercalcemia; Kidney Diseases; Parathyroid Hormone; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Sevelamer | 2011 |
Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?
Topics: Cardiovascular Diseases; Chronic Disease; Homeostasis; Humans; Kidney Diseases; Phosphates; Phosphorus; Predictive Value of Tests; Risk Factors | 2011 |
Therapeutic interventions for chronic kidney disease-mineral and bone disorders: focus on mortality.
Topics: Animals; Bone Diseases, Metabolic; Bone Remodeling; Calcimimetic Agents; Chelating Agents; Chronic Disease; Diet; Evidence-Based Medicine; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Diseases; Parathyroid Hormone; Phosphorus; Renal Dialysis; Treatment Outcome; Vitamin D | 2011 |
[Hypertension, CKD and bone metabolism].
Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Bone and Bones; Bone Density; Calcium; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Hypertension; Kidney Diseases; Osteoclasts; Osteoporosis; Phosphorus; Receptor Activator of Nuclear Factor-kappa B; Renin-Angiotensin System; Thiazides | 2011 |
Chronic kidney disease--mineral and bone disorder: a complex scenario.
Topics: Bone and Bones; Calcitriol; Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Minerals; Parathyroid Hormone; Phosphorus; Vascular Calcification | 2011 |
[Calcium pros and cons significance and risk of phosphorus supplementation. The risk of dietary phosphorus intake].
Topics: Aging; Cardiovascular Diseases; Chronic Disease; Food Analysis; Glomerular Filtration Rate; Humans; Kidney Diseases; Phosphorus; Phosphorus, Dietary; Risk; Vascular Calcification | 2011 |
FGF23 and PTH--double agents at the heart of CKD.
Topics: Calcium; Cardiovascular Physiological Phenomena; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Diseases; Parathyroid Hormone; Phosphorus; Vitamin D | 2012 |
[Kidney and bone update : the 5-year history and future of CKD-MBD. About the guideline of the Japanese Society for Dialysis Therapy].
Topics: Adult; Bone and Bones; Calcium; Child; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Dialysis; Humans; Japan; Kidney Diseases; Parathyroid Glands; Phosphorus; Practice Guidelines as Topic; Societies, Medical | 2012 |
[Kidney and bone update : the 5-year history and future of CKD-MBD. Vascular calcification in CKD patients].
Topics: Bone Diseases, Metabolic; Calcium; Carbamates; Chelating Agents; Chronic Disease; Disease Progression; Humans; Kidney Diseases; Minerals; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Polyamines; Prognosis; Sevelamer; Vascular Calcification; Vitamin D | 2012 |
[Kidney and bone update : the 5-year history and future of CKD-MBD. Bone fragility in the aged hemodialysis patients].
Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diphosphonates; Fractures, Spontaneous; Homeostasis; Humans; Kidney Diseases; Minerals; Naphthalenes; Osteoporosis; Phosphorus; Renal Dialysis; Risk | 2012 |
The role of sevelamer in achieving the kidney disease outcomes quality initiative (K/DOQI) guidelines for hyperphosphatemia.
Topics: Chronic Disease; Epoxy Compounds; Humans; Kidney Failure, Chronic; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Polyethylenes; Practice Guidelines as Topic; Quality Assurance, Health Care; Sevelamer; Treatment Outcome | 2004 |
[Pathogenesis of secondary hyperparathyroidism and renal bone disease].
Topics: Aluminum; Animals; Bone Diseases, Metabolic; Chronic Disease; Humans; Hyperparathyroidism, Secondary; Hypocalcemia; Kidney Diseases; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Receptors, Calcitriol; Receptors, Calcium-Sensing; Vitamin D Deficiency | 2004 |
[Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
Topics: Bone Density; Bone Diseases, Metabolic; Calcitonin; Chronic Disease; Diphosphonates; Epoxy Compounds; Furosemide; Humans; Hyperparathyroidism, Secondary; Ion Exchange Resins; Kidney Diseases; Kidney Transplantation; Pamidronate; Parathyroidectomy; Phosphorus; Phosphorus, Dietary; Polyamines; Polyethylenes; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Testosterone; United States; Vitamin D; Vitamin D Deficiency | 2004 |
[K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
Topics: Aluminum; Biomarkers; Bone and Bones; Bone Diseases, Metabolic; Calcium; Calcium, Dietary; Chronic Disease; Femoral Neck Fractures; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Diseases; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Practice Guidelines as Topic; Vitamin D; Vitamin D Deficiency | 2004 |
Reducing the burden of cardiovascular calcification in patients with chronic kidney disease.
Topics: Calcinosis; Calcium; Chronic Disease; Coronary Artery Disease; Humans; Kidney Diseases; Phosphorus | 2005 |
Lanthanum carbonate.
Topics: Animals; Chronic Disease; Clinical Trials as Topic; Humans; Kidney Diseases; Lanthanum; Phosphorus; Treatment Outcome | 2006 |
Mineral metabolism and mortality in patients with chronic kidney disease.
Topics: Calcium; Chronic Disease; Humans; Kidney Diseases; Kidney Failure, Chronic; Minerals; Parathyroid Hormone; Phosphorus | 2007 |
Management of chronic kidney disease mineral-bone disorder.
Topics: Bone Density Conservation Agents; Bone Diseases; Calcifediol; Chronic Disease; Cinacalcet; Diet; Humans; Hyperparathyroidism; Kidney Diseases; Kidney Failure, Chronic; Minerals; Naphthalenes; Parathyroid Hormone; Phosphates; Phosphorus; Vitamin D | 2007 |
[Parathyroid and bone. Mineral and bone disorder and parathyroid function in chronic kidney disease].
Topics: Bone Diseases, Metabolic; Calcinosis; Chronic Disease; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Oxidative Stress; Phosphorus; Vascular Diseases; Vitamin D Deficiency | 2007 |
Bone and mineral disorders in pre-dialysis CKD.
Topics: Bone Density Conservation Agents; Chronic Disease; Comorbidity; Disease Progression; Ergocalciferols; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hyperparathyroidism; Hyperphosphatemia; Kidney Diseases; Phosphorus; Vitamin D; Vitamin D Deficiency | 2008 |
Impact of Ca/P disorders on risks and comorbidities.
Topics: Calcium; Chronic Disease; Comorbidity; Humans; Kidney Diseases; Phosphorus | 2008 |
Skeletal muscle in hypophosphatemia and phosphorus deficiency.
Topics: Acute Disease; Alcoholism; Animals; Chronic Disease; Humans; Hypophosphatemia, Familial; Muscular Diseases; Phosphorus | 1978 |
Calcium and phosphorus metabolism in chronic uremia.
Topics: Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Dihydroxycholecalciferols; Drug Resistance; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Intestinal Absorption; Kidney Failure, Chronic; Kinetics; Metabolic Diseases; Osteitis Fibrosa Cystica; Osteomalacia; Parathyroid Glands; Parathyroid Hormone; Phosphates; Phosphorus; Uremia; Vitamin D | 1975 |
[Blood serum inorganic phosphorus: diagnostic significance and method of determination (review of the literature)].
Topics: Chronic Disease; Humans; Liver Diseases; Methods; Phosphorus; Pseudohypoparathyroidism; Rickets | 1991 |
[The most frequent hormonal disorders found in chronic hepatopathy].
Topics: Adrenocorticotropic Hormone; Brain; Calcifediol; Calcium; Chronic Disease; Estradiol; Estrogens; Female; Follicle Stimulating Hormone; Glucose; Growth Hormone; Hormones; Humans; Hypothalamo-Hypophyseal System; Hypothyroidism; Insulin; Liver Cirrhosis, Alcoholic; Liver Diseases; Luteinizing Hormone; Male; Melatonin; Neurotransmitter Agents; Parathyroid Hormone; Phosphorus; Pituitary Gland; Prolactin; Renin-Angiotensin System; Somatomedins; Testosterone; Thyroid Hormones; Thyrotropin-Releasing Hormone; Vasopressins; Vitamin D | 1985 |
[Disturbances of calcium/phosphorus metabolism in chronic renal disease].
Topics: Adult; Calcium; Chronic Disease; Feces; Female; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Nephritis; Phosphorus; Transplantation; Vitamin D | 1974 |
The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood.
Topics: Acute Disease; Amino Acids; Animals; Brain Diseases; Child; Child, Preschool; Chronic Disease; Creatinine; Dimercaprol; Drug Synergism; Edetic Acid; Fanconi Syndrome; Follow-Up Studies; Humans; Infant; Lead; Lead Poisoning; Levulinic Acids; Penicillamine; Phosphorus; Rabbits | 1968 |
28 trial(s) available for phosphorus and Chronic Disease
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Oral paricalcitol as antiproteinuric agent in chronic kidney disease.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; C-Reactive Protein; Calcium; Chronic Disease; Creatinine; Ergocalciferols; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Proteinuria; Treatment Outcome; Vitamin D | 2013 |
Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Drug Administration Schedule; Female; Humans; Hyperphosphatemia; Kidney Diseases; Lanthanum; Male; Middle Aged; Patient Satisfaction; Phosphorus; Renal Dialysis; Tablets; Time Factors; Treatment Outcome; United States | 2008 |
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results.
Topics: Adult; Aged; Calcium; Chronic Disease; Cinacalcet; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome; Vitamin D; Vitamins | 2008 |
Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Double-Blind Method; Female; Humans; Hyperphosphatemia; Kidney Diseases; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Simultaneous control of PTH and CaxP Is sustained over three years of treatment with cinacalcet HCl.
Topics: Adult; Aged; Biomarkers; Calcium; Canada; Chelating Agents; Chronic Disease; Cinacalcet; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Peritoneal Dialysis; Phosphates; Phosphorus; Renal Dialysis; Time Factors; Treatment Outcome; United States; Vitamin D | 2009 |
Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.
Topics: Aged; Biomarkers; Calcium; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Hypolipidemic Agents; Hypophosphatemia; Indoles; Kidney Diseases; Male; Middle Aged; Niacin; Phosphorus; Receptors, Immunologic; Receptors, Prostaglandin; Severity of Illness Index; Time Factors | 2010 |
Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
Topics: Adolescent; Bone Density; Calcitriol; Calcium; Calcium Channel Agonists; Child; Child, Preschool; Chronic Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endpoint Determination; Female; Follow-Up Studies; Growth; Hormone Replacement Therapy; Humans; Hypoparathyroidism; Kidney Function Tests; Long-Term Care; Magnesium; Male; Parathyroid Hormone; Phosphorus; Treatment Outcome; Vitamin D; Weight Gain | 2010 |
Vitamin D receptor activator reduces oxidative stress in hemodialysis patients with secondary hyperparathyroidism.
Topics: Aged; Aged, 80 and over; Calcitriol; Calcium; Chronic Disease; Female; Free Radical Scavengers; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Oxidative Stress; Parathyroid Hormone; Phosphorus; Receptors, Calcitriol; Renal Dialysis; Serum Albumin | 2011 |
Efficacy and safety of cinacalcet for the treatment of secondary hyperparathyroidism in patients with advanced chronic kidney disease before initiation of regular dialysis.
Topics: Adult; Aged; Calcimimetic Agents; Calcium; Chronic Disease; Cinacalcet; Compassionate Use Trials; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Severity of Illness Index; Treatment Outcome; Vitamin D | 2012 |
Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot study.
Topics: Aged; Biomarkers; Brachial Artery; Calcium; Chelating Agents; Chronic Disease; Coronary Artery Disease; Disease Progression; Endothelium, Vascular; Humans; Iowa; Kidney Diseases; Lanthanum; Middle Aged; Phosphorus; Pilot Projects; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Time Factors; Treatment Outcome; Vascular Calcification; Vasodilation | 2012 |
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.
Topics: Aged; Calcium; Chronic Disease; Double-Blind Method; Ergocalciferols; Female; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus | 2004 |
Effect of whole-body vibration exercise on lumbar bone mineral density, bone turnover, and chronic back pain in post-menopausal osteoporotic women treated with alendronate.
Topics: Accidental Falls; Aged; Aged, 80 and over; Alendronate; Alkaline Phosphatase; Back Pain; Bone Density; Bone Remodeling; Calcium; Chronic Disease; Exercise; Female; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Phosphorus; Vibration | 2005 |
Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis.
Topics: Calcium; Chronic Disease; Cinacalcet; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Treatment Outcome; Vitamin D | 2005 |
A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4.
Topics: Adult; Aged; Aged, 80 and over; Calcium; Capsules; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Vitamins | 2006 |
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
Topics: Acetates; Adult; Age Factors; Aged; Calcium; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Chronic Disease; Female; Humans; Kidney Diseases; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2007 |
A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Bicarbonates; Chelating Agents; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Kidney Diseases; Lipids; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2007 |
Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D.
Topics: Adult; Analysis of Variance; Asian People; Biomarkers; Calcium; Cholecalciferol; Chronic Disease; Dietary Supplements; Female; Follow-Up Studies; Humans; India; Male; Parathyroid Hormone; Phosphorus; Rickets; Time Factors; Vitamin D; Vitamin D Deficiency | 2008 |
Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis.
Topics: Aged; Australia; Bicarbonates; Biomarkers; Calcium; Chelating Agents; Cholesterol, LDL; Chronic Disease; Down-Regulation; Europe; Female; Humans; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Severity of Illness Index; Time Factors; Treatment Outcome; Vitamin D; Vitamins | 2008 |
Effect of the mode of calcitriol administration on PTH-ionized calcium relationship in uraemic patients with secondary hyperparathyroidism.
Topics: Administration, Oral; Calcitriol; Calcium; Chronic Disease; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Uremia | 1995 |
Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Calcitriol; Calcium; Calcium Carbonate; Chronic Disease; Cross-Over Studies; Cyclic AMP; Dose-Response Relationship, Drug; Female; Humans; Hypoparathyroidism; Male; Middle Aged; Parathyroid Hormone; Peptide Fragments; Phosphorus; Recombinant Proteins; Teriparatide | 1996 |
Long-term effects of intravenous 1 alpha (OH)D3 combined with CaCO3 and low-calcium dialysis on secondary hyperparathyroidism and biochemical bone markers in patients on chronic hemodialysis.
Topics: Adult; Alkaline Phosphatase; Aluminum; Biomarkers; Bone and Bones; Bone Density; Calcium; Calcium Carbonate; Chronic Disease; Dialysis Solutions; Diaphyses; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Femur Neck; Humans; Hydrogen-Ion Concentration; Hydroxycholecalciferols; Hyperparathyroidism, Secondary; Injections, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Peptide Fragments; Phosphates; Phosphorus; Procollagen; Radiography; Renal Dialysis | 1996 |
Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone.
Topics: Amino Acids; Body Height; Calcification, Physiologic; Calcium; Chronic Disease; Collagen; Collagen Type I; Dexamethasone; Glucocorticoids; Head; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Longitudinal Studies; Lung Diseases; Peptides; Phosphorus; Weight Gain | 1997 |
A 1H-decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls.
Topics: Adult; Antipsychotic Agents; Cerebral Cortex; Chlorpromazine; Chronic Disease; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphates; Phosphorus; Phosphorylcholine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1999 |
[Galstena therapy of some hepatobiliary diseases].
Topics: Adult; Aged; Biliary Tract Diseases; Chronic Disease; Drug Combinations; Female; Humans; Liver Diseases; Male; Middle Aged; Phosphorus; Phytotherapy; Plant Preparations; Protective Agents; Sulfates | 2001 |
Furosemide effect on mineral status of parenterally nourished premature neonates with chronic lung disease.
Topics: Adenosine Monophosphate; Calcium; Chronic Disease; Furosemide; Homeostasis; Humans; Hyperparathyroidism; Infant, Newborn; Infant, Premature; Lung Diseases; Parenteral Nutrition, Total; Phosphorus | 1990 |
[Use of vitamin D 2 and its metabolites in chronic glomerulonephritis in children].
Topics: Adolescent; Calcitriol; Calcium; Child; Child, Preschool; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Clinical Trials as Topic; Ergocalciferols; Glomerulonephritis; Humans; Hydroxycholecalciferols; Phosphorus | 1989 |
The treatment of osteoporosis. A report of a double blind clinical therapeutic trial.
Topics: Aged; Alkaline Phosphatase; Back Pain; Blood Proteins; Bronchitis; Calcium; Chronic Disease; Clinical Trials as Topic; Diethylstilbestrol; Drug Synergism; Emphysema; Female; Hemorrhage; Humans; Lactates; Male; Methyltestosterone; Middle Aged; Osteoporosis; Phosphorus; Radiography; Time Factors; Urea; Vagina; Vitamin D | 1969 |
179 other study(ies) available for phosphorus and Chronic Disease
| Article | Year |
|---|---|
Evaluating the association of vitamin D3, parathyroid hormone, and C-reactive protein serum levels in patients with an acute psychotic episode: a cross-sectional study in tertiary centre in Iran.
Topics: C-Reactive Protein; Calcium; Cholecalciferol; Chronic Disease; Cross-Sectional Studies; Humans; Iran; Methamphetamine; Parathyroid Hormone; Phosphorus; Psychotic Disorders; Vitamin D | 2023 |
Illness Perceptions, Self-Care Management, and Clinical Outcomes According to Age-Group in Korean Hemodialysis Patients.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Cross-Sectional Studies; Female; Health Behavior; Hemoglobins; Humans; Male; Middle Aged; Phosphorus; Potassium; Renal Dialysis; Republic of Korea; Self Care; Serum Albumin; Surveys and Questionnaires | 2019 |
[Differential-diagnostic features of combined periapical lesions].
Topics: Calcium; Chronic Disease; Diagnosis, Differential; Estradiol; Female; Humans; Hydrocortisone; Immunoglobulins; Male; Periapical Periodontitis; Periodontium; Phosphorus; Radiography; Saliva | 2013 |
Dietary phosphorus excess: a risk factor in chronic bone, kidney, and cardiovascular disease?
Topics: Biomarkers; Bone Diseases, Metabolic; Cardiovascular Diseases; Chronic Disease; Congresses as Topic; Diet; Evidence-Based Medicine; Fast Foods; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Food Additives; Humans; Nutritional Sciences; Phosphorus; Renal Insufficiency, Chronic; Risk Factors; Societies, Scientific; United States | 2013 |
High prevalence of secondary hyperparathyroidism in chronic kidney disease patients on dialysis in Argentina.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Argentina; Biomarkers; Bone and Bones; Calcitriol; Calcium; Child; Child, Preschool; Chronic Disease; Diabetic Nephropathies; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Prevalence; Renal Dialysis; Young Adult | 2013 |
Factors related with the progression of chronic kidney disease.
Topics: Aged; Anemia; Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetic Nephropathies; Disease Progression; Female; Glomerular Filtration Rate; Hematinics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Proteinuria; Retrospective Studies; Risk Factors; Uric Acid | 2013 |
The calcium-phosphorus in guidelines for CKD-MBD.
Topics: Bone Diseases; Calcium; Chronic Disease; Guidelines as Topic; Humans; Kidney Diseases; Phosphorus; Practice Guidelines as Topic; Water-Electrolyte Imbalance | 2008 |
Consistent control of mineral and bone disorder in incident hemodialysis patients.
Topics: Aged; Biomarkers; Bone Diseases, Metabolic; Calcium; Chronic Disease; Cohort Studies; Female; Humans; Incidence; Kidney Diseases; Male; Metabolic Diseases; Middle Aged; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Proportional Hazards Models; Renal Dialysis; Risk Assessment; Time Factors | 2008 |
Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.
Topics: Adult; Aged; Calcitriol; Case-Control Studies; Chronic Disease; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hypophosphatemia; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prospective Studies; Remission, Spontaneous; Time Factors | 2008 |
Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate.
Topics: Adult; Aged; Biomarkers; Calcium; Chronic Disease; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Health Surveys; Humans; Hydroxycholecalciferols; Kidney; Kidney Diseases; Male; Middle Aged; Models, Biological; Nutrition Surveys; Parathyroid Hormone; Phosphorus; Severity of Illness Index; United States; Up-Regulation | 2009 |
Phosphorus and survival: key questions that need answers.
Topics: Chronic Disease; Clinical Trials as Topic; Cohort Studies; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney Diseases; Models, Biological; Multivariate Analysis; Phosphates; Phosphorus; Phosphorus, Dietary; Treatment Outcome; Vitamin D | 2009 |
Taking aim at targets.
Topics: Calcium; Cardiovascular Diseases; Chronic Disease; Humans; Kidney Diseases; Outcome Assessment, Health Care; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Risk Factors | 2009 |
Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA.
Topics: Aged; Aged, 80 and over; Ankle; Arteries; Blood Pressure; Brachial Artery; Chronic Disease; Cross-Sectional Studies; Elasticity; Female; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Peripheral Vascular Diseases; Phosphorus; Pulsatile Flow; Radial Artery; United States; Up-Regulation | 2009 |
The ubiquitous nature and elusive role of phosphorus and vascular calcification.
Topics: Calcinosis; Chronic Disease; Humans; Kidney Diseases; Phosphorus; Vascular Diseases | 2009 |
The correlation between dental calculus and disturbed mineral metabolism in paediatric patients with chronic kidney disease.
Topics: Adolescent; Calcinosis; Child; Chronic Disease; Creatinine; Dental Calculus; Female; Humans; Hydrogen-Ion Concentration; Kidney Diseases; Magnesium; Male; Minerals; Phosphorus; Prognosis; Saliva; Urea; Vascular Diseases | 2009 |
Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression.
Topics: Calcium; Chronic Disease; Death; Depression; Hospitalization; Humans; Kidney Failure, Chronic; Phosphorus; Renal Dialysis | 2009 |
In-center nocturnal hemodialysis: another option in the management of chronic kidney disease.
Topics: Adult; Alkaline Phosphatase; Antihypertensive Agents; Attitude of Health Personnel; Biomarkers; Calcium; Chronic Disease; Circadian Rhythm; Feasibility Studies; Female; Health Knowledge, Attitudes, Practice; Hematinics; Hemodialysis Units, Hospital; Hemoglobins; Humans; Iron; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Program Evaluation; Quality of Life; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2009 |
Association of preventive health care with atherosclerotic heart disease and mortality in CKD.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Calcium; Chronic Disease; Cohort Studies; Creatinine; Glycated Hemoglobin; Guideline Adherence; Heart Diseases; Humans; Kidney Diseases; Outcome Assessment, Health Care; Parathyroid Hormone; Phosphorus; Preventive Health Services; Retrospective Studies | 2009 |
Outcomes predicted by phosphorous in chronic kidney disease: a retrospective CKD-inception cohort study.
Topics: Aged; Aged, 80 and over; Biomarkers; Chronic Disease; Cohort Studies; Female; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Phosphorus; Predictive Value of Tests; Prognosis; Renal Replacement Therapy; Retrospective Studies; Survival Analysis | 2010 |
Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study.
Topics: Adult; Aged; C-Reactive Protein; Calcium; Calcium Phosphates; Chronic Disease; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Inflammation; Interleukin-6; Kidney Diseases; Logistic Models; Male; Middle Aged; Minerals; Parathyroid Hormone; Phosphorus | 2009 |
Can we improve the quality of life for dialysis patients?
Topics: Chronic Disease; Health Surveys; Hemoglobins; Humans; Kidney Diseases; Phosphorus; Quality of Life; Renal Dialysis | 2009 |
Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Topics: Attitude of Health Personnel; Biomarkers; Bone Diseases, Metabolic; Calcium; Chelating Agents; Chronic Disease; Cinacalcet; Evidence-Based Medicine; Glomerular Filtration Rate; Guideline Adherence; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Practice Patterns, Physicians'; Renal Dialysis; Saudi Arabia; Surveys and Questionnaires; Treatment Outcome; Vitamin D; Vitamin D Deficiency | 2010 |
Is it time to modify the target range for serum phosphorus levels in chronic kidney disease (CKD).
Topics: Chronic Disease; Humans; Kidney Diseases; Phosphorus; Reference Values; Renal Dialysis | 2010 |
Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
Topics: Administration, Oral; Aged; Biomarkers; Bone Density Conservation Agents; Bone Remodeling; C-Reactive Protein; Calcitriol; Calcium; Chelating Agents; Cholecalciferol; Chronic Disease; Darbepoetin alfa; Dietary Supplements; Ergocalciferols; Erythropoietin; Female; Hematinics; Humans; Hypertrophy, Left Ventricular; Inflammation Mediators; Kidney Diseases; Male; Middle Aged; Natriuretic Peptide, Brain; Parathyroid Hormone; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Serum Albumin; Sevelamer; Time Factors; Treatment Outcome; Vitamin D; Vitamin D Deficiency; Vitamins | 2010 |
Mineral and bone disease pattern in elderly haemodialysis patients.
Topics: Biomarkers; Bone Diseases, Metabolic; C-Reactive Protein; Calcium; Chronic Disease; Cohort Studies; Cross-Sectional Studies; Female; Humans; Kidney Diseases; Male; Parathyroid Hormone; Phosphorus; Prognosis; Prospective Studies; Renal Dialysis; Vitamin D | 2010 |
Bone mineral densitometry in patients on hemodialysis: difference between genders and what to measure.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Bone Density; Bone Diseases, Metabolic; Calcium; Chronic Disease; Female; Forearm; Hip; Humans; Kidney Diseases; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Parathyroid Hormone; Phosphorus; Renal Dialysis; Sex Characteristics | 2010 |
Differential effects of 17beta-estradiol and raloxifene on bone and lipid metabolism in rats with chronic kidney disease and estrogen insufficiency.
Topics: Animals; Atrophy; Bone Density Conservation Agents; Calcitriol; Calcium; Cholesterol; Chronic Disease; Estradiol; Estrogens; Female; Hyperplasia; Kidney Diseases; Mammary Glands, Animal; Organ Size; Parathyroid Hormone; Phosphorus; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tibia; Uterus | 2010 |
Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.
Topics: Adult; alpha-2-HS-Glycoprotein; Biomarkers; Blood Proteins; Calcium; Chi-Square Distribution; Chronic Disease; Coronary Angiography; Coronary Stenosis; Cross-Sectional Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Predictive Value of Tests; Prognosis; Regression Analysis; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Turkey; Vitamin D | 2010 |
[Phosphorus and calcium metabolism and the cardiovascular system status in patients with early-stage chronic renal disease].
Topics: Calcium; Cardiovascular Diseases; Cardiovascular System; Chronic Disease; Dihydroxycholecalciferols; Female; Humans; Kidney Diseases; Male; Parathyroid Hormone; Phosphorus; Seasons; Severity of Illness Index | 2010 |
Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation?
Topics: Animals; Calcium; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Humans; Hyperparathyroidism, Secondary; Kidney; Kidney Diseases; Klotho Proteins; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Receptors, Fibroblast Growth Factor; Sodium-Potassium-Exchanging ATPase | 2010 |
The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.
Topics: Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Evidence-Based Medicine; Humans; Kidney Diseases; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Treatment Outcome; United States; Vascular Diseases; Vitamin D | 2010 |
[Vascular calcification in chronic kidney disease].
Topics: Arrhythmias, Cardiac; Bone Diseases, Metabolic; Calcinosis; Calcium; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kidney Diseases; Phosphorus; Radiography; Vascular Diseases | 2010 |
Dialysis after kidney transplant failure: do patients start in a worse condition than the general population with chronic kidney disease?
Topics: Adult; Aged; Anemia; Calcium; Cardiovascular Diseases; Chronic Disease; Darbepoetin alfa; Erythropoietin; Female; Follow-Up Studies; Graft Rejection; Humans; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Postoperative Complications; Recurrence; Renal Dialysis; Retrospective Studies; Risk Factors; Treatment Outcome | 2011 |
Achievement of recommended treatment targets for bone and mineral metabolism in haemodialysis patients using paricalcitol: an observational study.
Topics: Aged; Biomarkers, Pharmacological; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcium; Chronic Disease; Ergocalciferols; Female; Humans; Hyperparathyroidism, Secondary; Injections, Intravenous; Kidney Diseases; Male; Middle Aged; Observation; Parathyroid Hormone; Phosphorus; Prospective Studies; Renal Dialysis; Sweden | 2011 |
Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction.
Topics: Aged; Aged, 80 and over; Chronic Disease; Disease Progression; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Phosphorus | 2011 |
Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.).
Topics: Algorithms; Biomarkers; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Calcinosis; Calciphylaxis; Calcium; Chelation Therapy; Chronic Disease; Combined Modality Therapy; Diagnostic Imaging; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Kidney Transplantation; Minerals; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Receptors, Cell Surface; Reference Values; Renal Dialysis; Renal Insufficiency, Chronic; Vitamin D | 2011 |
Relationship between serum phosphorus and the progression of advanced chronic kidney disease.
Topics: Aged; Bicarbonates; Biomarkers; Calcitriol; Calcium; Chelating Agents; Chronic Disease; Confounding Factors, Epidemiologic; Disease Progression; Diuretics; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Predictive Value of Tests; Prospective Studies | 2011 |
Effectiveness of treatment with oral paricalcitol in patients with pre-dialysis chronic kidney disease.
Topics: Aged; Aged, 80 and over; Body Mass Index; Calcium; Chronic Disease; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Evaluation; Endpoint Determination; Ergocalciferols; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2011 |
Fractional excretion and reabsorption in chronic kidney disease.
Topics: Absorption; Calcium; Chronic Disease; Glomerular Filtration Rate; Homeostasis; Humans; Kidney Diseases; Kidney Tubules; Models, Biological; Phosphorus; Uric Acid | 2012 |
Mean arterial pressure and pulse pressure are associated with different clinical parameters in chronic haemodialysis patients.
Topics: Alkaline Phosphatase; Biomarkers; Blood Pressure; Blood Proteins; Body Mass Index; Cholesterol, HDL; Chronic Disease; Diabetic Nephropathies; Erythropoietin; Female; Glomerulonephritis; Humans; Male; Phosphorus; Pyelonephritis; Regression Analysis; Renal Dialysis; Sex Factors; Statistics as Topic; Time Factors; Treatment Outcome; Ultrafiltration | 2003 |
Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease.
Topics: Adenosine Triphosphate; Animals; Aspartate Aminotransferases; Body Weight; Chronic Disease; Disease Models, Animal; Disease Progression; Liver; Liver Cirrhosis; Liver Diseases; Magnetic Resonance Spectroscopy; Male; Organ Size; Phosphorus; Phosphorylation; Rats; Rats, Sprague-Dawley; Serum Albumin | 2003 |
A new approach to the treatment of chronic leukaemia with 32P.
Topics: Chronic Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Phosphorus; Phosphorus Radioisotopes; Radioactivity | 1955 |
Triethylene thiophosphoramide in the treatment of chronic leukemia.
Topics: Chronic Disease; Leukemia; Phosphorus; Phosphorus, Dietary; Thiotepa | 1955 |
Radioactive phosphorus in the treatment of chronic leukemias: long-term results over a period of 15 years.
Topics: Chronic Disease; Humans; Leukemia; Phosphorus; Phosphorus Radioisotopes | 1959 |
[Comparative evaluation of the effectiveness of certain therapeutic methods in chronic leukemias; roentgen rays, radioactive phosphorus, urethane, embichine, arsenic, myleran. IV].
Topics: Arsenic; Busulfan; Chronic Disease; Leukemia; Phosphorus; Phosphorus, Dietary; Radioactivity; Urethane; X-Rays | 1959 |
[Comparative evaluation of the effectiveness of certain therapeutic methods in chronic leukemias; roentgen rays, radioactive phosphorus, urethane, embichine, arsenic, myleran. V].
Topics: Arsenic; Busulfan; Chronic Disease; Leukemia; Phosphorus; Phosphorus, Dietary; Radioactivity; Urethane; X-Rays | 1959 |
[Treatment of chronic leukemias with radioactive phosphorus. Early results in the treatment of 10 patients].
Topics: Chronic Disease; Humans; Leukemia; Phosphorus; Phosphorus Radioisotopes | 1961 |
[Blood bilirubin and alkaline phosphatases in patients with mitrotricuspid valvulopathies].
Topics: Alkaline Phosphatase; Bilirubin; Chronic Disease; Disease; Heart Diseases; Heart Valve Diseases; Humans; Mitral Valve; Myocarditis; Phosphorus; Rheumatic Heart Disease; Tricuspid Valve | 1959 |
Comparative survival times of x-ray treated versus P32 treated patients with chronic leukemias under the program of titrated, regularly spaced total-body irradiation.
Topics: Chronic Disease; Humans; Leukemia; Phosphorus; Phosphorus Radioisotopes; Radiotherapy; Whole-Body Irradiation; X-Rays | 1955 |
[Treatment of chronic leukemia with radioactive phosphorus].
Topics: Chronic Disease; Humans; Leukemia; Phosphorus; Phosphorus Radioisotopes | 1955 |
Leukocyte survival in chronic leukaemia with the aid of a tracer and a therapy dose of P32.
Topics: Chronic Disease; Humans; Leukemia; Leukocytes; Phosphorus; Phosphorus Radioisotopes | 1962 |
The relative rates of formation of new leukocytes in patients with acute and chronic leukemias measured by the uptake of radioactive phosphorus in the isolated desoxyribosenucleic acid.
Topics: Chronic Disease; Humans; Leukemia; Leukocytes; Phosphorus | 1952 |
FGF-23 is elevated by chronic hyperphosphatemia.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypoparathyroidism; Male; Middle Aged; Phosphorus | 2004 |
1,25-Dihydroxyvitamin D3 but not cinacalcet HCl (Sensipar/Mimpara) treatment mediates aortic calcification in a rat model of secondary hyperparathyroidism.
Topics: Animals; Aortic Diseases; Calcinosis; Calcitriol; Calcium; Calcium Channel Agonists; Chronic Disease; Cinacalcet; Disease Models, Animal; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley | 2005 |
Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States.
Topics: Adult; Aged; Black or African American; Calcifediol; Calcium; Chronic Disease; Comorbidity; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prevalence; Prospective Studies; Risk Factors; Seasons; Sunlight; Topography, Medical; United States; Vitamin D Deficiency; White People | 2005 |
Vitamin D deficiency in CKD: why should we care?
Topics: Calcitriol; Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Cohort Studies; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Phosphorus; Vitamin D Deficiency | 2005 |
Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Topics: Alkaline Phosphatase; Amino Acids; Bilirubin; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Calcium; Chronic Disease; Cross-Sectional Studies; Female; Femur; Humans; Liver Diseases; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Phosphorus; Postmenopause | 2005 |
Relationship of phosphorus and calcium-phosphorus product with mortality in CKD.
Topics: Adult; Aged; C-Reactive Protein; Calcium; Cardiovascular Diseases; Cause of Death; Chronic Disease; Cohort Studies; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Mortality; Phosphorus; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk | 2005 |
[X-ray analysis of bone damage caused by chronic phosphorus poisoning].
Topics: Adult; Bone and Bones; Chronic Disease; Humans; Male; Mandible; Middle Aged; Occupational Exposure; Phosphorus; Radiography | 2005 |
Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study.
Topics: Aged; Albuminuria; alpha-2-HS-Glycoprotein; Biomarkers; Blood Proteins; Calcium; Chronic Disease; Cohort Studies; Comorbidity; Coronary Disease; Creatinine; Cystatin C; Cystatins; Diabetes Complications; Female; Glomerular Filtration Rate; Humans; Hypercholesterolemia; Hypertension; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Obesity; Phosphorus; Prospective Studies; San Francisco | 2006 |
Paricalcitol for treatment of secondary hyperparathyroidism in CKD patients.
Topics: Acetates; Calcitriol; Calcium; Calcium Compounds; Chronic Disease; Cinacalcet; Clinical Trials, Phase III as Topic; Ergocalciferols; Humans; Hyperparathyroidism, Secondary; Kidney Diseases; Naphthalenes; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic | 2006 |
Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism.
Topics: Animals; Calcinosis; Calcitriol; Calcium; Chronic Disease; Dihydroxycholecalciferols; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Hyperparathyroidism, Secondary; Phosphorus; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Calcitriol; Uremia; Vascular Diseases; Vitamin D-Binding Protein; Vitamins | 2007 |
NHANES III: influence of race on GFR thresholds and detection of metabolic abnormalities.
Topics: Adult; Bicarbonates; Black People; Blood Pressure; Chronic Disease; Creatinine; Differential Threshold; Female; Glomerular Filtration Rate; Hemoglobins; Hispanic or Latino; Humans; Kidney Diseases; Male; Middle Aged; Nutrition Surveys; Phosphorus; Racial Groups; Uric Acid; White People | 2007 |
Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Calcitriol; Calcium; Cardiovascular System; Chronic Disease; Creatinine; Ergocalciferols; Fibrosis; Male; Nephrectomy; Parathyroid Hormone; Peptidyl-Dipeptidase A; Phosphorus; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renin | 2007 |
Phosphate binders: hold the calcium?
Topics: Calcium; Chronic Disease; Humans; Kidney Diseases; Phosphorus; Phosphorus Metabolism Disorders; Renal Dialysis | 2006 |
The case against calcium-based phosphate binders.
Topics: Calcinosis; Calcium; Chronic Disease; Humans; Kidney Diseases; Phosphorus; Phosphorus Metabolism Disorders; Renal Dialysis; Uremia; Vascular Diseases | 2006 |
Association of disorders in mineral metabolism with progression of chronic kidney disease.
Topics: Aged; Calcium; Calcium Metabolism Disorders; Chronic Disease; Disease Progression; Humans; Kidney Diseases; Male; Middle Aged; Phosphorus; Phosphorus Metabolism Disorders; Prospective Studies | 2006 |
Serum phosphorus and the risk of progression of chronic kidney disease.
Topics: Chronic Disease; Disease Progression; Humans; Kidney Diseases; Phosphorus | 2007 |
Change in serum uric acid between baseline and 1-year follow-up and its associated factors in male subjects.
Topics: Adult; Bilirubin; Blood Urea Nitrogen; Cholesterol; Chronic Disease; Cohort Studies; Creatinine; Follow-Up Studies; Humans; Male; Middle Aged; Phosphorus; Regression Analysis; Triglycerides; Uric Acid | 2008 |
The details bedevil DCOR.
Topics: Age Factors; Calcium; Cardiovascular Diseases; Chelating Agents; Chronic Disease; Humans; Kidney Diseases; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2007 |
Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
Topics: Adolescent; Adult; Aged; Biomarkers; Calcium; Chronic Disease; Community Health Services; Cross-Sectional Studies; Databases, Factual; Early Diagnosis; Female; Foundations; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Mass Screening; Middle Aged; Nutrition Surveys; Parathyroid Hormone; Phosphorus; Risk Factors; United States | 2008 |
The mechanism of phosphorus as a cardiovascular risk factor in CKD.
Topics: Animals; Calcinosis; Cardiovascular Diseases; Cells, Cultured; Chronic Disease; Humans; Kidney Diseases; Mice; Phosphorus; Risk Factors; Vascular Diseases | 2008 |
Higher serum creatinine concentrations in black patients with chronic kidney disease: beyond nutritional status and body composition.
Topics: Adult; Aged; Black or African American; Blood Glucose; Blood Urea Nitrogen; Body Composition; Body Height; Body Weight; Chronic Disease; Cohort Studies; Creatinine; Electric Impedance; Female; Humans; Kidney Diseases; Male; Middle Aged; Nutritional Status; Phosphorus; Renal Dialysis; Serum Albumin; Transferrin; United States; Up-Regulation | 2008 |
The bone-renal axis in early chronic kidney disease: an emerging paradigm.
Topics: Bone and Bones; Calcitriol; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Homeostasis; Humans; Kidney; Kidney Diseases; Parathyroid Hormone; Phosphorus; Vitamin D Deficiency | 2008 |
[Study on pathological basis of yang-deficiency and yin-deficiency in patients with chronic nephritis by urinary analysis of creatinine, urea, potassium, phosphorus and magnesium].
Topics: Chronic Disease; Creatinine; Female; Humans; Magnesium; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Nephritis; Phosphorus; Potassium; Regression Analysis; Urea | 1984 |
[Dynamics of the liver enzyme profile of workers in the phosphorus industry and of patients with chronic phosphorus poisoning following the use of hyperbaric oxygenation].
Topics: Adult; Chemical Industry; Chronic Disease; Clinical Enzyme Tests; Female; Humans; Hyperbaric Oxygenation; Kazakhstan; Liver; Male; Middle Aged; Occupational Diseases; Phosphorus | 1984 |
Muscle intracellular electrolytes in patients with chronic uremia.
Topics: Adolescent; Adult; Aged; Body Fluids; Child; Chlorides; Chronic Disease; Female; Humans; Hypokalemia; Intracellular Fluid; Magnesium; Male; Middle Aged; Muscles; Phosphorus; Potassium; Renal Dialysis; Sodium; Uremia; Water-Electrolyte Balance | 1983 |
Calcium levels in normal and hypertensive pregnant patients.
Topics: Adult; Blood Proteins; Calcium; Chronic Disease; Female; Gestational Age; Humans; Hypertension; Magnesium; Phosphorus; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Serum Albumin | 1984 |
[Clinical manifestations of chronic occupational phosphorus poisoning].
Topics: Adult; Chronic Disease; Female; Humans; Male; Middle Aged; Occupational Diseases; Phosphorus; Syndrome | 1983 |
[Parathormone and calcitonin in the blood in chronic kidney diseases].
Topics: Adolescent; Adult; Aged; Calcitonin; Calcium; Chronic Disease; Female; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus | 1982 |
[Effect of cysteine hydrochloride on the morphological changes in the liver in chronic yellow phosphorus poisoning].
Topics: Animals; Chemical and Drug Induced Liver Injury; Chronic Disease; Cysteine; Female; Liver; Male; Phosphorus; Rats | 1982 |
[Functional and morphologic characteristics of leukocytes in patients with chronic phosphorus poisoning].
Topics: Adult; Chronic Disease; Histocytochemistry; Humans; Leukocyte Count; Leukocytes; Middle Aged; Occupational Diseases; Phosphorus | 1982 |
Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: a 31phosphorous magnetic resonance spectroscopic imaging study.
Topics: Adult; Antipsychotic Agents; Brain Mapping; Chronic Disease; Dominance, Cerebral; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phospholipids; Phosphorus; Psychiatric Status Rating Scales; Reference Values; Schizophrenia; Schizophrenic Psychology; Temporal Lobe | 1995 |
Correction of chronic metabolic acidosis in haemodialysed patients by acetate-free biofiltration does not influence parathyroid function.
Topics: Acidosis; Bicarbonates; Calcium; Chronic Disease; Hemofiltration; Humans; Hyperparathyroidism, Secondary; Infusions, Intravenous; Kidney Diseases; Parathyroid Hormone; Phosphorus; Renal Dialysis | 1995 |
Experimental acidemia and muscle cell pH in chronic acidosis and renal failure.
Topics: Acidosis; Acids; Animals; Chronic Disease; Electric Stimulation; Hydrogen-Ion Concentration; Kidney Failure, Chronic; Magnetic Resonance Spectroscopy; Male; Muscle Contraction; Muscles; Phosphorus; Rats; Rats, Sprague-Dawley | 1995 |
Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy.
Topics: Adenosine Diphosphate; Adult; Brain Chemistry; Chronic Disease; Energy Metabolism; Exercise; Female; Humans; Magnetic Resonance Spectroscopy; Mitochondrial Myopathies; Muscle, Skeletal; Occipital Lobe; Ophthalmoplegia; Phosphorus; Phosphorylation; Thioctic Acid | 1995 |
Intramuscular calcitriol for uraemic children with severe hyperparathyroidism and hypercalcaemia.
Topics: Administration, Oral; Adolescent; Calcitriol; Calcium; Child; Child, Preschool; Chronic Disease; Creatinine; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Immunoenzyme Techniques; Infant; Injections, Intramuscular; Male; Parathyroid Hormone; Phosphorus; Uremia | 1994 |
In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers.
Topics: Adenosine Triphosphate; Adult; Aged; Alcohol Drinking; Alcoholism; Chronic Disease; Esters; Female; Humans; Liver; Liver Cirrhosis, Alcoholic; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphates; Phosphorus; Reference Values | 1995 |
Cerebral phosphorus-31 magnetic resonance spectroscopy in patients with chronic hepatic encephalopathy.
Topics: Adult; Aged; Brain; Chronic Disease; Female; Hepatic Encephalopathy; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Phosphates; Phosphorus | 1994 |
[Characteristics of clinical aspects and diagnosis of chronic bronchitis in workers of a phosphorus plant].
Topics: Adult; Air Pollutants, Occupational; Bronchitis; Chemical Industry; Chronic Disease; Humans; Male; Middle Aged; Occupational Diseases; Phosphorus | 1994 |
Effect of acute and chronic hyponatremia on brain buffering in rats.
Topics: Acute Disease; Administration, Inhalation; Animals; Brain; Buffers; Carbon Dioxide; Cerebrovascular Circulation; Chronic Disease; Deamino Arginine Vasopressin; Hydrogen-Ion Concentration; Hyponatremia; Magnetic Resonance Spectroscopy; Male; Phosphorus; Rats; Rats, Sprague-Dawley | 1993 |
Effect of systemic hypotension on cerebral energy metabolism during chronic cerebral vasospasm in primates.
Topics: Animals; Brain; Cerebrovascular Circulation; Chronic Disease; Energy Metabolism; Female; Glucose; Hypotension; Ischemic Attack, Transient; Macaca fascicularis; Magnetic Resonance Spectroscopy; Oxygen; Phosphorus | 1993 |
Hyperparathyroidism associated with a chronic hypothyroid state.
Topics: Adenoma; Animals; Antithyroid Agents; Calcium; Chronic Disease; Disease Models, Animal; Female; Hyperparathyroidism; Hyperplasia; Hypothyroidism; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phosphorus; Propylthiouracil; Rats; Rats, Sprague-Dawley; Survival Rate; Thyroid Gland; Thyrotropin; Thyroxine | 1997 |
The detection of chronic heart graft rejection by 31P NMR spectroscopy.
Topics: Adenosine Triphosphate; Animals; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Magnetic Resonance Spectroscopy; Myocardium; Phosphocreatine; Phosphorus; Phosphorus Isotopes; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 1999 |
Creatine kinase reaction rates in rat brain during chronic ischemia.
Topics: Aging; Animals; Brain; Brain Ischemia; Chronic Disease; Kinetics; Nuclear Magnetic Resonance, Biomolecular; Phosphocreatine; Phosphorus; Rats; Rats, Wistar | 1998 |
Bone turnover in short-term and long-term home parenteral nutrition for benign disease.
Topics: Adult; Aged; Aluminum; Amino Acids; Biomarkers; Bone and Bones; Calcium; Chronic Disease; Female; Humans; Intestinal Diseases; Magnesium; Male; Middle Aged; Osteocalcin; Parathyroid Hormone; Parenteral Nutrition, Home; Phosphorus; Time Factors; Vitamin D | 2000 |
Etiology of nephrocalcinosis in preterm neonates: association of nutritional intake and urinary parameters.
Topics: Ascorbic Acid; Birth Weight; Calcium; Chronic Disease; Citrates; Creatinine; Gestational Age; Humans; Infant Food; Infant Nutritional Physiological Phenomena; Infant, Newborn; Infant, Premature; Lung Diseases; Nephrocalcinosis; Phosphorus; Prospective Studies; Ultrasonography; Urine | 2000 |
Electrolyte disturbances in patients with chronic, stable asthma: effect of therapy.
Topics: Adult; Asthma; Calcium; Chronic Disease; Cross-Sectional Studies; Female; Humans; Hypophosphatemia; Magnesium; Male; Phosphorus; Potassium; Prospective Studies; Sodium; Water-Electrolyte Imbalance | 2001 |
Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury.
Topics: Animals; Calcium; Chlorine; Chronic Disease; Contrast Media; Electron Probe Microanalysis; Gadolinium DTPA; Kinetics; Magnetic Resonance Imaging; Myocardial Infarction; Myocardium; Phosphorus; Potassium; Rabbits; Radiography; Sodium; Sulfur | 2002 |
[Chronic metabolic acidosis in dairy cows].
Topics: Acidosis; Animals; Calcium; Cattle; Cattle Diseases; Chronic Disease; Female; Glucose; Hydrogen-Ion Concentration; Magnesium; Phosphorus; Potassium; Urea | 1977 |
[Study of the state of myocardial carbohydrate-phosphorus metabolism in chronic poisoning by a mixture of pesticides].
Topics: Animals; Carbohydrate Metabolism; Chronic Disease; Dimethoate; Drug Combinations; Hexachlorocyclohexane; Male; Myocardium; Pesticides; Phosphorus; Poisoning; Rabbits | 1976 |
1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Calcium; Child; Child, Preschool; Chronic Disease; Creatinine; Cystinosis; Dihydroxycholecalciferols; Humans; Hydroxycholecalciferols; Hypocalcemia; Hypoparathyroidism; Hypophosphatemia, Familial; Kidney Failure, Chronic; Phosphorus; Rickets; Vitamin D Deficiency | 1975 |
Calcium and phosphorus homeostasis in man. Effect of corticosteroids.
Topics: Adult; Aged; Calcium; Chronic Disease; Cyclic AMP; Drug Administration Schedule; Female; Homeostasis; Humans; Infusions, Parenteral; Intestinal Absorption; Lung Diseases, Obstructive; Malabsorption Syndromes; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prednisone | 1976 |
[Gasometry, 2,3-DPG and plasma inorganic phosphorus in chronic dialysed renal patients].
Topics: Adult; Blood Gas Analysis; Chronic Disease; Female; Glycerophosphates; Humans; Kidney Diseases; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Renal Dialysis; Respiration | 1978 |
[Metabolic characteristics of Dupuytren's disease].
Topics: Adult; Aged; Blood Proteins; Calcium; Chronic Disease; Dupuytren Contracture; Female; Glycoproteins; Glycosaminoglycans; Humans; Hydroxyproline; Male; Middle Aged; Phosphorus; Postoperative Period; Sialic Acids | 1979 |
The effects of diseases of the liver on serum 25-hydroxyvitamin D and on the serum binding protein for vitamin D and its metabolites.
Topics: Animals; Calcium; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Phosphorus; Protein Binding; Rabbits; Vitamin D | 1979 |
Soft tissue calcification in chronic dialysis patients.
Topics: Adolescent; Adult; Calcinosis; Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Kidney; Kidney Diseases; Lung; Male; Middle Aged; Myocardium; Parathyroid Glands; Phosphorus; Renal Dialysis; Stomach; Uremia | 1977 |
[X-ray and biochemical parallels of the changes in calcium and phosphorus content in the bones of white rats with chronic lead poisoning].
Topics: Animals; Bone and Bones; Calcium; Chronic Disease; Lead Poisoning; Male; Phosphorus; Photometry; Radiography; Rats; Time Factors | 1977 |
Effects of arsenic cell metabolism and cell proliferation: cytogenetic and biochemical studies.
Topics: Aged; Arsenic Poisoning; Chromosome Aberrations; Chronic Disease; DNA; Female; Humans; Lymphocytes; Male; Middle Aged; Phosphorus; RNA; Time Factors | 1977 |
[Chronic renal incompetence in pyelonephritis].
Topics: Ammonia; Calcium; Chronic Disease; Glycosuria; Humans; Kidney; Phosphorus; Potassium; Pyelonephritis; Sodium; Transaminases | 1976 |
Alteration of calcium metabolism in chronic pancreatitis.
Topics: Calcium; Calcium Metabolism Disorders; Chronic Disease; Female; Humans; Male; Pancreatitis; Phosphorus | 1976 |
The muscle cell in chronic alcoholism: the possible role of phosphate depletion in alcoholic myopathy.
Topics: Alcoholism; Chlorides; Chronic Disease; Creatine Kinase; Extracellular Space; Fructose-Bisphosphate Aldolase; Glycogen; Humans; Lactates; Male; Membrane Potentials; Muscle Cramp; Muscles; Muscular Diseases; Phosphates; Phosphorus; Potassium; Sodium; Water | 1975 |
Myopathy and neuropathy associated with osteomalacia.
Topics: Abortion, Spontaneous; Action Potentials; Adolescent; Adult; Alkaline Phosphatase; Avitaminosis; Biopsy; Calcium; Chronic Disease; Diarrhea; Electromyography; Female; Follow-Up Studies; Humans; Hypocalcemia; Lactation Disorders; Motor Neurons; Muscular Dystrophies; Neural Conduction; Osteomalacia; Phosphorus; Pregnancy; Socioeconomic Factors | 1975 |
[Objective criteria for the selection of dermatoplastic operations in treating trophic ulcers].
Topics: Adolescent; Adult; Aged; Chronic Disease; Foot; Foot Diseases; Humans; Leg; Leg Ulcer; Middle Aged; Phosphorus; Surgery, Plastic; Ulcer | 1975 |
Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats.
Topics: Aging; Animals; Brain Ischemia; Cerebral Cortex; Cerebrovascular Circulation; Chronic Disease; Dementia, Vascular; Hippocampus; Magnetic Resonance Spectroscopy; Male; Memory Disorders; Phosphorus; Protons; Rats; Rats, Sprague-Dawley; Spatial Behavior | 1992 |
[The pathomorphological changes in the internal organs in experimental chronic red phosphorus poisoning].
Topics: Animals; Brain; Chronic Disease; Colloids; Female; Male; Phosphorus; Poisoning; Rats; Time Factors | 1992 |
Modification of diet in renal disease.
Topics: Blood Pressure; Chronic Disease; Clinical Trials as Topic; Dietary Proteins; Humans; Kidney Diseases; Phosphorus | 1992 |
Decreased phosphorus metabolite concentrations and alkalosis in chronic cerebral infarction.
Topics: Adenosine Triphosphate; Adult; Aged; Alkalosis; Brain; Cerebral Infarction; Chronic Disease; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Male; Phosphates; Phosphocreatine; Phospholipids; Phosphorus | 1992 |
[State of the Krebs cycle in the kidneys of rats with chronic phosphorus intoxication].
Topics: Animals; Chromatography, Gas; Chronic Disease; Citric Acid Cycle; Kidney; Male; Oxidoreductases; Phosphorus; Rats | 1991 |
Serum vitamin D metabolites and bone mineralization in young children with chronic low to moderate lead exposure.
Topics: Bone Density; Calcification, Physiologic; Calcitonin; Calcium; Child, Preschool; Chronic Disease; Cohort Studies; Female; Humans; Hydroxycholecalciferols; Infant; Lead; Lead Poisoning; Magnesium; Male; Parathyroid Hormone; Phosphorus; Regression Analysis | 1991 |
[Hemoglobin-oxygen affinity in acute exacerbation of chronic respiratory failure].
Topics: 2,3-Diphosphoglycerate; Adult; Aged; Aged, 80 and over; Chronic Disease; Diphosphoglyceric Acids; Humans; Middle Aged; Oxygen; Partial Pressure; Phosphorus; Respiratory Insufficiency | 1990 |
Cerebral energy metabolism in experimental canine hydrocephalus.
Topics: Acute Disease; Animals; Brain; Cerebrospinal Fluid Pressure; Chronic Disease; Dogs; Energy Metabolism; Hydrocephalus; Magnetic Resonance Spectroscopy; Phosphorus; Reference Values | 1990 |
[Lipid peroxidation and the state of the antioxidant system in patients with chronic phosphorus poisoning].
Topics: Adult; Antioxidants; Chronic Disease; Erythrocyte Membrane; Free Radicals; Humans; Lipid Peroxidation; Middle Aged; Phosphorus; Sulfhydryl Compounds; Superoxide Dismutase | 1990 |
Short-term effects of parathyroidectomy on plasma biochemistry in chronic uremia.
Topics: Alkaline Phosphatase; Aluminum; Bone and Bones; Calcifediol; Calcium; Chronic Disease; Cohort Studies; Deferoxamine; gamma-Glutamyltransferase; Humans; Hyperparathyroidism, Secondary; Osteocalcin; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors; Uremia | 1989 |
Phosphorus nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in chronic alcoholics.
Topics: Adult; Alcoholism; Chronic Disease; Exercise; Humans; Hydrogen-Ion Concentration; Ischemia; Magnetic Resonance Spectroscopy; Middle Aged; Muscles; Phosphorus; Rest | 1989 |
Bone disease in chronic childhood cholestasis. I. Vitamin D absorption and metabolism.
Topics: 25-Hydroxyvitamin D 2; Absorption; Adolescent; Bone and Bones; Bone Diseases; Calcifediol; Calcitriol; Calcium; Child; Child, Preschool; Cholestasis, Intrahepatic; Chronic Disease; Ergocalciferols; Female; Humans; Infant; Male; Minerals; Phosphorus; Vitamin D; Vitamin D-Binding Protein; Vitamin E | 1989 |
[Humoral factors of nonspecific immunity in people in contact with phosphorus-containing compounds].
Topics: Adult; Antibody Formation; Chronic Disease; Humans; Immunity, Innate; Kazakhstan; Middle Aged; Occupational Diseases; Phosphorus | 1986 |
Response of serum 1,25(OH)2D3 to variation of ionized calcium during chronic acidosis.
Topics: Acidosis; Ammonium Chloride; Animals; Blood Gas Analysis; Calcitriol; Calcium; Chronic Disease; Creatinine; Cyclic AMP; Egtazic Acid; Hydrogen-Ion Concentration; Magnesium; Phosphorus; Rats; Rats, Inbred Strains | 1985 |
Renal calcification in preterm infants: pathophysiology and long-term sequelae.
Topics: Birth Weight; Calcium; Chronic Disease; Follow-Up Studies; Furosemide; Humans; Infant, Newborn; Infant, Premature, Diseases; Kidney Calculi; Lung Diseases; Phosphorus; Risk Factors; Serum Albumin; Ultrasonography | 1988 |
The effects of chronic vitamin D deficiency on the skeleton in the adult rabbit.
Topics: Animals; Body Weight; Bone and Bones; Calcium; Chronic Disease; Eating; Kidney Function Tests; Osteomalacia; Phosphorus; Rabbits; Vitamin D Deficiency | 1988 |
[Effect of hyperbaric oxygenation on tissue respiratory function and lipid peroxidation in experimental chronic phosphorus poisoning].
Topics: Animals; Blood Cells; Chronic Disease; Hyperbaric Oxygenation; Lipid Peroxidation; Liver; Male; Oxygen Consumption; Partial Pressure; Phosphorus; Rats; Skin | 1988 |
[Value of various biochemical indicators of the bile for elaboration of the therapeutic tactics in chronic cholecystitis].
Topics: Aged; Bile; Bilirubin; Cholecystectomy; Cholecystitis; Cholic Acids; Chronic Disease; Female; Humans; Lipids; Male; Middle Aged; Phosphorus; Prognosis | 1988 |
[The role of free radicals in the pathogenesis of chronic poisoning with phosphorus compounds].
Topics: Animals; Chronic Disease; Free Radicals; Humans; Lipid Peroxidation; Liver; Oxidative Phosphorylation; Phosphorus | 1988 |
[Factors influencing the progress of kidney function disorders].
Topics: Animals; Blood Coagulation Factors; Chronic Disease; Diet; Dietary Proteins; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Lipids; Phosphorus | 1988 |
[Pathogenesis of diabetic osteopathy].
Topics: Adolescent; Adult; Aged; Calcium; Calcium-Binding Proteins; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Osteoporosis; Phosphorus | 1988 |
A study of natural history of chronic glomerulonephritis. XI. Is limited-protein diet delaying progression of chronic renal disease?
Topics: Adolescent; Adult; Chronic Disease; Dietary Proteins; Female; Glomerulonephritis; Humans; Male; Middle Aged; Phosphorus | 1986 |
[Evaluation of calcium-phosphorus metabolism in chronic liver diseases in children].
Topics: Adolescent; Calcium; Child; Child, Preschool; Chronic Disease; Female; Humans; Infant; Liver Diseases; Male; Phosphorus | 1987 |
[Morphological and morphometric research on the liver of rats with chronic phosphorus poisoning under different nutritional conditions].
Topics: Animal Nutritional Physiological Phenomena; Animals; Chronic Disease; Liver; Necrosis; Phosphorus; Rats; Rats, Inbred Strains; Time Factors | 1987 |
Solute kinetics in hypertonic hemodiafiltration and standard hemodialysis.
Topics: Blood; Chronic Disease; Creatinine; Female; Humans; Inulin; Kinetics; Male; Middle Aged; Models, Biological; Netilmicin; Parathyroid Hormone; Phosphorus; Renal Dialysis; Toxins, Biological; Ultrafiltration; Urea; Uremia; Uric Acid | 1986 |
[Oxygen metabolism in the skin in chronic phosphorus poisoning].
Topics: Chronic Disease; Humans; Hypoxia; Oxygen Consumption; Phosphorus; Skin | 1986 |
Renal excretion of divalent ions in response to chronic acidosis: evidence that systemic pH is not the controlling variable.
Topics: Acidosis; Acidosis, Respiratory; Animals; Calcium; Cations, Divalent; Chronic Disease; Kidney; Magnesium; Male; Phosphorus; Rats; Rats, Inbred Strains | 1987 |
[Effect of yellow phosphorus on the functional activity of antioxidant enzymes in the liver].
Topics: Animals; Chronic Disease; Enzyme Activation; Liver; Oxidoreductases; Phosphorus; Rabbits | 1986 |
[Treatment of toxic lesions of the liver in chronic occupational phosphorus poisoning].
Topics: Chemical and Drug Induced Liver Injury; Chronic Disease; Combined Modality Therapy; Humans; Occupational Diseases; Phosphorus | 1986 |
Effects of a low phosphorus, low nitrogen diet supplemented with essential amino acids and ketoanalogues on serum triglycerides of chronic uremic patients.
Topics: Adult; Aged; Amino Acids, Essential; Chronic Disease; Creatinine; Diet, Vegetarian; Female; Food, Fortified; Humans; Keto Acids; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Nitrogen; Phosphorus; Renal Dialysis; Sex Factors; Time Factors; Triglycerides; Uremia | 1986 |
Hypervitaminosis A and calcium-regulating hormones in the rat.
Topics: Acute Disease; Animals; Body Weight; Bone and Bones; Calcium; Chronic Disease; Hypervitaminosis A; In Vitro Techniques; Male; Parathyroid Hormone; Phosphorus; Rats; Rats, Inbred Strains; Vitamin D | 1986 |
[Hormones regulating phosphorus-calcium metabolism in patients with systemic lupus erythematosus nephritis and Bright disease].
Topics: Adolescent; Adult; Calcitonin; Calcium; Chronic Disease; Female; Glomerulonephritis; Humans; Lupus Erythematosus, Systemic; Middle Aged; Parathyroid Hormone; Phosphorus | 1985 |
[Combined measurements in sera and exudates for the evaluation of inflammation stages].
Topics: Acid Phosphatase; Acute Disease; Alkaline Phosphatase; Alpha-Globulins; Animals; Beta-Globulins; Calcium; Chlorides; Chronic Disease; Exudates and Transudates; gamma-Globulins; Inflammation; Mucoproteins; Phospholipids; Phosphorus; Potassium; Rabbits; Serum Albumin; Serum Globulins; Sodium | 1970 |
[Carbohydrate-phosphorus metabolism in leukocytes of schizophrenics].
Topics: Acute Disease; Adenosine Triphosphatases; Adult; Chronic Disease; Clinical Enzyme Tests; Glycogen; Glycolysis; Humans; Leukocytes; Middle Aged; Phosphorus; Schizophrenia; Transferases | 1970 |
[Heat exchange and the blood energy system in children with chronic pyelonephritis].
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Body Temperature Regulation; Child; Chronic Disease; Female; Humans; Male; Phosphocreatine; Phosphorus; Pyelonephritis | 1971 |
Toxic hepatitis, especially on the hepatic injuries caused by acute poisonings and chronic alcoholism in medical examiner's cases.
Topics: Adolescent; Adult; Aged; Alcoholism; Autopsy; Chemical and Drug Induced Liver Injury; Child; Chronic Disease; Coroners and Medical Examiners; Fatty Liver; Glycosaminoglycans; Humans; Hydroxyproline; Japan; Liver; Liver Cirrhosis; Middle Aged; Phosphorus; Poisoning; Suicide | 1973 |
[Evolutive hyperparathyroidism and chronic uremia in substitute dialysis. Apropos of 2 cases].
Topics: Acute Kidney Injury; Adult; Antacids; Biopsy; Calcium; Chronic Disease; Female; Humans; Hyperparathyroidism; Kidney Diseases; Male; Middle Aged; Phosphorus; Renal Dialysis; Transplantation, Homologous; Uremia; Vitamin D | 1971 |
[Cholelithiasis in primary hyperparathyroidism].
Topics: Adult; Age Factors; Aged; Calcium; Cholelithiasis; Chronic Disease; Female; Humans; Hyperparathyroidism; Male; Middle Aged; Obesity; Phosphorus; Sex Factors | 1974 |
Chronic nephritis in the dog.
Topics: Animals; Blood Proteins; Blood Urea Nitrogen; Calcium; Chronic Disease; Dog Diseases; Dogs; Erythrocyte Count; Glomerulonephritis; Hematocrit; Leukocyte Count; Nephritis; Nephritis, Interstitial; Phosphorus; Pyelonephritis | 1974 |
[Characteristics of carbohydrate-phosphorus and electrolyte metabolism in the erythrocytes of patients with progressive muscular dystrophy and in their closest relations].
Topics: Adenosine Triphosphate; Adolescent; Adult; Age Factors; Carbohydrate Metabolism; Charcot-Marie-Tooth Disease; Chronic Disease; Electrolytes; Erythrocytes; Facial Muscles; Female; Glycolysis; Humans; Male; Middle Aged; Muscular Dystrophies; Pentoses; Phosphorus; Shoulder; Syndrome; Thiamine Pyrophosphate | 1974 |
[Some characteristics of the peripheral microcirculation and capillary permeability in schizophrenia].
Topics: Adult; Amitriptyline; Capillary Permeability; Chronic Disease; Drug Therapy, Combination; Female; Humans; Insulin; Male; Mental Disorders; Microcirculation; Phosphorus; Phosphorus Radioisotopes; Psychotropic Drugs; Remission, Spontaneous; Schizophrenia; Schizophrenia, Catatonic; Schizophrenia, Paranoid | 1974 |
Effect of nutritional hyperparathyroidism on experimental periodontitis in the dog.
Topics: Alveolar Process; Animals; Body Weight; Bone Diseases; Calcium; Chronic Disease; Deficiency Diseases; Dental Plaque; Diet; Dogs; Gingivitis; Hyperparathyroidism, Secondary; Parathyroid Glands; Periodontitis; Phosphorus; Tooth Mobility | 1973 |
[Idiopathic familial chronic hypoparathyroidism in infancy. Description of 2 cases classifiable in the Whitaker syndrome].
Topics: Adrenal Insufficiency; Calcium; Candidiasis; Child; Child, Preschool; Chronic Disease; Female; Humans; Hypoparathyroidism; Male; Phosphorus; Syndrome | 1973 |
[Calcium and phosphorus content in the gastric juice].
Topics: Adult; Aged; Calcium; Chronic Disease; Colorimetry; Duodenal Ulcer; Gastric Juice; Gastritis; Humans; Middle Aged; Phosphorus; Photometry; Stomach Neoplasms | 1973 |
[Evaluation of vitamin D deficiency in pulmonary tuberculosis].
Topics: Alkaline Phosphatase; Calcium; Chronic Disease; Humans; Phosphorus; Tuberculosis, Pulmonary; Vitamin D Deficiency | 1973 |
[Change in the blood phosphorus content in alcoholism and alcoholic psychoses].
Topics: Adult; Alcoholism; Chronic Disease; Female; Humans; Male; Middle Aged; Phosphorus; Psychoses, Alcoholic | 1973 |
[Some characteristics of phosphorus-calcium metabolism and the bone system pathology in chronic uremia].
Topics: Adolescent; Adult; Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Middle Aged; Phosphorus; Renal Dialysis; Uremia | 1973 |
Comparison of factors regulating red cell 2,3-diphosphoglycerate (2,3-DPG) in acute and chronic hypoxemia.
Topics: Acid-Base Equilibrium; Acute Disease; Blood; Carbon Dioxide; Chronic Disease; Diphosphoglyceric Acids; Erythrocytes; Hemoglobins; Humans; Hydrogen-Ion Concentration; Hypoxia; Lung Diseases, Obstructive; Metabolic Diseases; Oxygen; Partial Pressure; Phosphorus; Spectrophotometry; Time Factors | 1974 |
[Functional disorders of the pancreas in pancreatic lithiasis--compared with chronic pancreatitis without calcinosis].
Topics: Adult; Calcinosis; Calcium; Cholecystokinin; Cholesterol; Chronic Disease; Glucose Tolerance Test; Humans; Insulin; Iodine Radioisotopes; Male; Middle Aged; Pancreas; Pancreatic Diseases; Pancreatitis; Phosphorus; Triolein | 1972 |
[Capillary kidney--experiences with chronic hemodialysis].
Topics: Calcium; Chronic Disease; Creatinine; Humans; Kidneys, Artificial; Liver Diseases; Metabolic Clearance Rate; Methods; Phosphorus; Urea | 1971 |
EEG frequency content related to chemical blood parameters in chronic uraemia.
Topics: Acid-Base Equilibrium; Adolescent; Adult; Blood Urea Nitrogen; Brain; Cerebrovascular Circulation; Chronic Disease; Creatinine; Electroencephalography; Electrolytes; Electromyography; Female; Hemoglobins; Humans; Male; Middle Aged; Neural Conduction; Nitrogen; Phosphorus; Regional Blood Flow; Uremia; Water-Electrolyte Balance | 1971 |
[Primary and chronic congenital hypomagnesemia with magnesium-dependent hypocalcemia].
Topics: Calcium; Child, Preschool; Chronic Disease; Female; Humans; Hypocalcemia; Infant; Infant, Newborn; Intestinal Absorption; Magnesium; Magnesium Deficiency; Malabsorption Syndromes; Male; Parathyroid Glands; Phosphorus; Seizures; Tetany | 1971 |
Chronic destructive periodontal disease in patients with presenile osteoporosis.
Topics: Adult; Aged; Aging; Alkaline Phosphatase; Calcium; Calcium Metabolism Disorders; Chronic Disease; Feces; Female; Humans; Male; Menopause; Middle Aged; Mouth, Edentulous; Nitrogen; Osteoporosis; Periodontal Diseases; Periodontal Index; Phosphorus | 1968 |
Magnesium balance studies in chronic alcoholism.
Topics: Adult; Alcoholism; Biopsy; Calcium; Chronic Disease; Diet Therapy; Humans; Magnesium; Magnesium Deficiency; Methods; Muscles; Phosphorus; Potassium; Substance Withdrawal Syndrome | 1969 |
[Effect of aluminum hydroxide on serum calcium, serum phosphorus and calcium turnover in uremic patients].
Topics: Acidosis, Renal Tubular; Adult; Aged; Aluminum; Bone Development; Bone Diseases; Calcium; Calcium Isotopes; Chronic Disease; Female; Humans; Hydroxides; Inulin; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Osteomalacia; Phosphorus; Pyelonephritis; Time Factors; Uremia | 1969 |
[Toxicity of sodium fluoride. 2. Chronic toxicity].
Topics: Animals; Body Weight; Calcium; Chronic Disease; Female; Fluoride Poisoning; Fluorides; Liver; Maternal-Fetal Exchange; Phosphorus; Pregnancy; Rats; Tooth | 1970 |
[Chronic case of Candida albicans mycosis of the oral cavity and nails as a major symptom of primary (idiopathic) hypoparathyroidism].
Topics: Adult; Alopecia Areata; Calcium; Candida; Candidiasis; Candidiasis, Oral; Child; Child, Preschool; Chronic Disease; Female; Humans; Hypoparathyroidism; Male; Nails; Phosphorus; Tetany | 1970 |
Causes of recurrent hypercalcemia after parathyroidectomy for primary hyperparathyroidism.
Topics: Adenoma; Calcium; Carcinoma; Chronic Disease; Diet; Humans; Hypercalcemia; Hyperparathyroidism; Hyperplasia; Middle Aged; Parathyroid Glands; Parathyroid Neoplasms; Phosphates; Phosphorus; Postoperative Complications | 1971 |
[The muscles in chro- nic uremia. Morphologic and biochemical findings obtained by means of needle biopsy].
Topics: Adolescent; Adult; Aged; Biopsy; Chlorides; Chronic Disease; Female; Glycogen; Histocytochemistry; Humans; Magnesium; Male; Middle Aged; Muscles; Phosphorus; Potassium; Sodium; Uremia; Water-Electrolyte Balance | 1967 |
Dietary programs and chronically uremic patients on and off dialysis.
Topics: Adult; Alkaline Phosphatase; Blood Urea Nitrogen; Body Weight; Chronic Disease; Creatinine; Diet Therapy; Dietary Proteins; Humans; Hydrogen-Ion Concentration; Kidney Function Tests; Middle Aged; Phosphorus; Potassium; Renal Dialysis; Sodium; Time Factors; Trace Elements; Uremia; Urine | 1968 |
[Chronic hyperparathyroidism associated with C-cell hyperplasia of the thyroid gland].
Topics: Alkaline Phosphatase; Calcitonin; Calcium; Chronic Disease; Female; Humans; Hypercalcemia; Hyperparathyroidism; Kidney Failure, Chronic; Malabsorption Syndromes; Middle Aged; Osteitis Fibrosa Cystica; Phosphorus; Thyroid Neoplasms | 1968 |
Renal osteodystrophy in course of periodic dialysis for chronic uremia.
Topics: Adolescent; Adult; Alkaline Phosphatase; Calcium; Child; Child, Preschool; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Humans; Male; Middle Aged; Osteitis Fibrosa Cystica; Osteomalacia; Osteoporosis; Osteosclerosis; Phosphorus; Renal Dialysis; Uremia; Vitamin D | 1968 |
Hyperparathyroid crisis.
Topics: Adenoma; Blood Urea Nitrogen; Calcium; Chronic Disease; Humans; Hypercalcemia; Hyperparathyroidism; Male; Middle Aged; Parathyroid Neoplasms; Phosphorus; Potassium | 1969 |
Vasopressin-resistant hyposthenuria in advanced chronic renal disease.
Topics: Adolescent; Adult; Alkaline Phosphatase; Blood Urea Nitrogen; Calcinosis; Calcium; Chronic Disease; Creatinine; Female; Humans; Hyperparathyroidism; Kidney Concentrating Ability; Kidney Diseases; Kidney Tubules; Male; Middle Aged; Osmolar Concentration; Phosphorus; Potassium; Sodium; Urea; Vasopressins | 1969 |
[Osteomalacia].
Topics: Acidosis, Renal Tubular; Adult; Bone and Bones; Calcium; Celiac Disease; Chronic Disease; Crohn Disease; Fanconi Syndrome; Gastrectomy; Gastrointestinal Diseases; Humans; Hypophosphatasia; Hypophosphatemia, Familial; Intestinal Absorption; Kidney Failure, Chronic; Metabolic Diseases; Osteomalacia; Pancreatitis; Parathyroid Hormone; Phosphorus; Radiography; Vitamin D; Vitamin D Deficiency | 1969 |